Other diseases of blood and blood-forming organs, wide

D3_BLOODOTHER

hematologic disease: A disease involving the hematopoietic system.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints D3_AGRANULOCYTOSIS D3_FUNCPOLYMORPHONUCNEUTRO D3_OTHERWHITECELL D3_SPLEENDISEASE D3_METHAEMOGLOBINAEMIA D3_OTHERBLOOD D3_OTHDISLYMPHORETANDRETICULOHIST D3_BLOODINOTH	9433
6. Filter based on genotype QC (FinnGen only)	9433

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF12

NAME	D3_BLOODOTHER
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	D3_AGRANULOCYTOSIS\|D3_FUNCPOLYMORPHONUCNEUTRO\|D3_OTHERWHITECELL\|D3_SPLEENDISEASE\|D3_METHAEMOGLOBINAEMIA\|D3_OTHERBLOOD\|D3_OTHDISLYMPHORETANDRETICULOHIST\|D3_BLOODINOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other diseases of blood and blood-forming organs, wide based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	61862	33444	27962
Only index persons	52577	29034	23543
Unadjusted period prevalence (%)
Whole population	0.87	0.96	0.78
Only index persons	0.99	1.07	0.90
Median age at first event (years)
Whole population	59.66	59.54	59.73
Only index persons	58.81	58.55	59.12

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9433	5312	4121
Unadjusted period prevalence (%)	1.81	1.81	1.82
Median age at first event (years)	59.40	56.92	62.60

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8559: Matched controls
85591

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D72.1

ICD-10 Finland

Eosinophilia

518.2

323.0

491

D70.89

ICD-10 Finland

Neutropenic splenomegaly

1450.6

323.0

1644

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

37.4

323.0

531

151

A49.9

ICD-10 Finland

Bacterial infection, unspecified

6.5

323.0

2198

4342

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

18.8

323.0

1881

1264

WW500

NOMESCO Finland

Blood transfusion

8.9

323.0

1052

1328

L03AA13

ATC

pegfilgrastim; parenteral

9.9

323.0

1081

1237

D75.1

ICD-10 Finland

Secondary polycythaemia

773.1

323.0

711

R50.9

ICD-10 Finland

Fever, unspecified

4.4

323.0

2242

6420

L01XX05

ATC

hydroxycarbamide; oral

32.8

323.0

704

233

H02AB02

ATC

dexamethasone; systemic

5.5

323.0

2000

4496

L03AA02

ATC

filgrastim; parenteral

11.5

323.0

837

798

JN4BD

NOMESCO Finland

Extensive body CT

4.1

323.0

1749

5016

XW000

NOMESCO Finland

Bone marrow biopsy

22.0

323.0

2009

1179

A04AA02

ATC

granisetron; systemic, transdermal

6.0

323.0

1254

2392

A03FA01

ATC

metoclopramide; systemic, rectal

3.7

323.0

2941

10600

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.7

323.0

1924

6241

D75.9

ICD-10 Finland

Disease of blood and blood-forming organs, unspecified

588.4

323.0

655

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

7.6

323.0

1022

1508

D70.82

ICD-10 Finland

Drug-induced neutropenia

2993.7

323.0

2400

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

25.6

323.0

528

219

D75.2

ICD-10 Finland

Essential thrombocytosis

330.1

323.0

830

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

290.5

323.0

1091

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.8

323.0

4762

26262

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

7.2

321.7

834

1267

ZX120

NOMESCO Finland

Intravenous

4.0

318.4

1450

4164

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

14.0

314.3

557

423

A04AA01

ATC

ondansetron; systemic, rectal

4.6

283.1

1075

2577

J01MA12

ATC

levofloxacin; systemic

2.8

269.2

2162

9304

L03AA14

ATC

lipegfilgrastim; parenteral

11.2

266.4

525

498

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

9.3

252.7

550

627

D72.9

ICD-10 Finland

Disorder of white blood cells, unspecified

126.7

250.9

270

N02AA05

ATC

oxycodone; systemic

2.9

230.5

1672

6664

JN4AD

NOMESCO Finland

Body CT examination

3.7

223.3

1070

3143

M04AA01

ATC

allopurinol; systemic

3.0

222.4

1511

5758

D45

ICD-10 Finland

Polycythaemia vera

18.1

221.5

353

203

115

Kela drug reimbursment

Breast cancer

3.6

221.3

1105

3358

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.2

221.1

3213

18457

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

13.1

217.5

395

314

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

4.6

195.6

733

1706

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.1

192.2

3214

19295

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

13.9

190.3

336

250

D64.9

ICD-10 Finland

Anaemia, unspecified

3.1

189.5

1192

4274

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

187.4

2296

11997

A02BC02

ATC

pantoprazole; systemic

2.0

185.2

5704

43067

A41.9

ICD-10 Finland

Sepsis, unspecified

5.4

182.1

584

1145

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

9.4

179.8

386

426

D73.5

ICD-10 Finland

Infarction of spleen

+∞

179.8

172

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.1

178.6

1104

3900

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.8

177.6

826

2344

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.5

173.6

1598

7192

H02AB06

ATC

prednisolone; systemic

1.9

172.2

4216

28899

A04AD12

ATC

aprepitant; systemic

7.4

172.0

429

604

D75.0

ICD-10 Finland

Familial erythrocytosis

246.2

165.0

169

Z51.5

ICD-10 Finland

Palliative care

3.8

164.8

773

2203

9962/3-C42.1

ICD-O-3

Essential thrombocythemia of bone marrow

50.9

164.0

199

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.6

157.5

491

928

XX3DW

NOMESCO Finland

Time consuming IT work

2.8

157.4

1163

4589

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.4

149.9

806

2556

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

10.7

149.5

299

289

ZX112

NOMESCO Finland

Subcutaneous

6.3

146.2

410

678

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

145.7

2029

11015

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

142.1

2634

15985

A04AA55

ATC

palonosetron, combinations; systemic

5.1

140.0

468

957

D73.1

ICD-10 Finland

Hypersplenism

+∞

135.8

130

B01AB05

ATC

enoxaparin; parenteral

1.9

133.2

2753

17285

HA1AA

NOMESCO Finland

X-ray mammography

3.0

132.8

859

3093

C03CA01

ATC

furosemide; systemic

1.9

132.4

2465

14903

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

3.1

130.4

783

2680

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.9

129.9

583

1590

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

4.2

129.6

529

1325

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

4.3

129.1

517

1271

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

12.3

126.3

235

196

WF049

NOMESCO Finland

Radiotherapy of metastasis

4.6

125.4

465

1060

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.2

124.8

716

2368

HAC20

NOMESCO Finland

Total mastectomy

3.8

124.5

561

1534

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.8

120.7

845

3195

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

12.8

120.0

219

175

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.5

119.8

606

1822

B01AB10

ATC

tinzaparin; parenteral

2.9

117.5

778

2836

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

24.4

117.0

168

D47.1

ICD-10 Finland

Chronic myeloproliferative disease

24.9

116.2

166

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.7

114.9

411

902

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

14.7

114.2

196

136

L02BG04

ATC

letrozole; oral

3.0

111.7

693

2415

WZC30

NOMESCO Finland

Teaching

2.2

111.2

1302

6458

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

3.1

110.4

663

2259

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.7

109.1

814

3190

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

7.6

107.3

262

356

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

4.1

106.3

442

1123

L02BA01

ATC

tamoxifen; oral

3.7

106.2

493

1380

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

3.1

104.1

612

2053

TGC00

NOMESCO Finland

Bronchial lavation

4.8

103.7

366

791

J01MA14

ATC

moxifloxacin; systemic

2.5

102.7

901

3864

J01DB01

ATC

cefalexin; oral

1.8

101.6

6818

58912

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

100.3

4208

31880

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

98.4

1889

11329

D75.8

ICD-10 Finland

Other specified diseases of blood and blood-forming organs

330.8

98.2

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

3.0

98.2

622

2193

130

Kela drug reimbursment

Malignant tumour

2.5

97.6

834

3521

L01XX35

ATC

anagrelide; oral

49.8

97.2

118

D69.5

ICD-10 Finland

Secondary thrombocytopenia

25.0

97.0

138

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.7

93.6

437

1227

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

6.0

93.1

270

465

JN6AD

NOMESCO Finland

CT of torso and neck

7.2

92.2

233

333

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

90.9

2339

15342

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

90.8

1022

4943

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

90.8

1815

10992

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

3.7

89.8

420

1180

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.9

88.7

588

2133

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

3.0

87.7

533

1825

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

87.4

800

3495

N02BE01

ATC

paracetamol; systemic, rectal

1.8

86.8

7103

62936

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

4.0

86.1

369

962

C83.1

ICD-10 Finland

Mantle cell lymphoma

18.0

85.4

135

PJA12

NOMESCO Finland

Sentinel node biopsy

2.4

84.1

756

3270

127

Kela drug reimbursment

Transplant complication

6.0

83.3

239

406

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

81.1

992

4963

JN4CD

NOMESCO Finland

Very extensive body CT

3.2

79.7

447

1445

SPAT1074

SPAT

Venesection

17.3

78.6

126

X76

ICPC

Malignant neoplasm breast female

4.9

78.1

266

553

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.6

78.0

371

1056

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

8.8

77.7

172

200

D73.9

ICD-10 Finland

Disease of spleen, unspecified

765.2

77.4

TPH00

NOMESCO Finland

Phlebotomy

11.4

77.2

148

132

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

13.4

76.5

136

103

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

6.2

76.2

214

354

WW300

NOMESCO Finland

Transfer of autologic stem cells

16.3

75.7

124

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

25.5

75.1

106

D70.80

ICD-10 Finland

Agranulocytic angina

+∞

75.1

ZX108

NOMESCO Finland

Inhalation

9.0

75.0

163

184

C50.99

ICD-10 Finland

Breast, unspecified

3.9

73.5

324

865

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

4.0

73.4

310

797

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.1

72.3

872

4322

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

72.0

915

4639

2888B

ICD-9 Finland

Diseases of white blood cells, Other specified disease of white blood cells[LEUCOPENIA]

+∞

72.0

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

15.4

71.7

120

L01BC06

ATC

capecitabine; oral

3.2

71.0

399

1291

D70.81

ICD-10 Finland

Neutropenia congenital

+∞

70.9

D46.7

ICD-10 Finland

Other myelodysplastic syndromes

19.9

70.9

108

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.1

69.9

853

4246

N05CF01

ATC

zopiclone; oral

1.6

69.5

2557

18199

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

5.3

69.3

221

427

B03XA02

ATC

darbepoetin alfa; parenteral

4.7

68.7

244

531

WF003

NOMESCO Finland

Adjuvant radiotherapy

3.2

68.6

382

1228

L03AB05

ATC

interferon alfa-2b; parenteral

15.6

68.5

114

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

10.1

67.7

138

139

R4110

NOMESCO Finland

Physiotherapy

1.6

67.4

2181

15004

H02AB09

ATC

hydrocortisone; systemic

4.0

67.4

282

719

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

66.9

1221

7087

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

66.6

1312

7811

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

66.2

2754

20128

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

5.6

66.2

202

371

WW200

NOMESCO Finland

Immunization

3.5

65.7

322

939

D70

ICD-10 Finland

Agranulocytosis

643.0

65.0

N02AX02

ATC

tramadol; systemic, rectal

1.5

65.0

3345

25627

PJA10

NOMESCO Finland

Exploration of lymph nodes

5.9

64.5

186

319

J01MA02

ATC

ciprofloxacin; systemic

1.5

64.4

3033

22771

WX402

NOMESCO Finland

General anaesthesia

1.8

64.2

1357

8255

M05BX04

ATC

denosumab; parenteral

2.7

63.1

462

1774

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

5.3

62.6

200

388

J05AB11

ATC

valaciclovir; oral

1.9

62.3

1091

6230

R72

ICD-10 Finland

Abnormality of white blood cells, not elsewhere classified

17.0

61.5

D73.4

ICD-10 Finland

Cyst of spleen

+∞

61.5

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

5.5

61.1

189

353

A06AD11

ATC

lactulose; oral

1.8

60.9

1135

6614

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

60.4

3200

24546

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

60.4

1706

11268

B99

ICD-10 Finland

Other and unspecified infectious diseases

4.2

60.1

238

577

A46

ICD-10 Finland

Erysipelas

1.8

59.5

1120

6544

ZX080

NOMESCO Finland

Image guided radiotherapy

3.9

59.2

258

682

ZX070

NOMESCO Finland

Intensity modified radiotherapy

4.0

58.6

246

629

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.7

58.5

205

440

JN3AD

NOMESCO Finland

Abdominal CT examination

2.2

58.3

658

3154

L02BG06

ATC

exemestane; oral

4.9

57.1

193

399

L04AA06

ATC

mycophenolic acid; systemic

4.4

56.7

213

491

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.4

55.9

521

2280

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

4.6

55.9

200

439

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

6.5

55.9

149

231

YNB10

NOMESCO Finland

Collection of stem cells for transplant

30.2

55.9

B99

ICPC

Blood/lymph/spleen disease other

13.2

55.6

NK6AN

NOMESCO Finland

Total body bone isotope imaging

3.2

54.1

305

989

UJF32

NOMESCO Finland

Coloscopy

1.5

54.0

2016

14223

9960/3-C42.1

ICD-O-3

Myeloproliferative neoplasm, NOS, of bone marrow

32.5

53.9

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

53.3

982

5683

R11

ICD-10 Finland

Nausea and vomiting

2.1

53.1

660

3297

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

15.6

53.1

Z31.5

ICD-10 Finland

Genetic counselling

2.5

53.0

428

1738

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

15.7

52.6

1XC02

NOMESCO Finland

6.9

52.5

135

199

28899

ICD-8 Finland

Agranulocytosis

+∞

52.1

TNE20

NOMESCO Finland

Bone marrow aspiration, pelvis

29.4

51.8

A41.8

ICD-10 Finland

Other specified sepsis

4.4

51.7

196

456

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

51.7

1372

8864

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.0

51.7

309

1042

212

Kela drug reimbursment

Gout

3.8

51.5

225

597

1CD02

NOMESCO Finland

6.8

51.1

132

196

129

Kela drug reimbursment

Idiopathic thrombocytopaenia or granulocytopenia

27.1

50.7

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

21.0

50.4

R06.0

ICD-10 Finland

Dyspnoea

1.5

50.3

1898

13387

189

Kela drug reimbursment

Imatinib

15.1

50.1

GD1AD

NOMESCO Finland

Thorax CT examination

2.5

49.5

400

1623

D73.8

ICD-10 Finland

Other diseases of spleen

490.7

49.4

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

49.4

664

3423

SPAT1255

SPAT

Intravenous administration of medicine

2.2

49.3

558

2676

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

49.3

636

3225

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

15.3

49.2

L04AD01

ATC

ciclosporin; systemic

3.7

49.2

222

606

WX110

NOMESCO Finland

Local anesthesy

1.4

49.1

5350

46361

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

3.6

48.8

229

646

N05AH02

ATC

clozapine; systemic

3.9

48.6

206

532

9961/3-C42.1

ICD-O-3

Primary myelofibrosis of bone marrow

19.4

47.8

JMA10

NOMESCO Finland

Transabdominal total splenectomy

8.4

47.6

107

129

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

3.9

47.4

203

530

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.3

47.3

464

2081

C91.7

ICD-10 Finland

Other lymphoid leukaemia

47.8

47.0

L01CB01

ATC

etoposide; systemic

9.3

47.0

107

R53

ICD-10 Finland

Malaise and fatigue

1.6

46.7

1500

10157

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.3

46.3

245

759

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.6

45.5

351

1386

N05BA04

ATC

oxazepam; oral

1.5

45.3

1845

13186

D73.0

ICD-10 Finland

Hyposplenism

450.1

45.3

C90.0

ICD-10 Finland

Multiple myeloma

5.4

45.2

139

259

N03AX16

ATC

pregabalin; oral

1.5

45.0

1799

12802

J01FF01

ATC

clindamycin; systemic

1.5

44.9

2060

15109

WF004

NOMESCO Finland

Palliative radiotherapy

3.6

44.8

208

582

9950/3-C42.1

ICD-O-3

Polycythemia vera of bone marrow

12.2

44.1

N05BA06

ATC

lorazepam; systemic, sublingual

2.3

44.1

434

1948

ZX121

NOMESCO Finland

Central venous catheter

9.7

44.1

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.9

43.9

732

4080

28900

ICD-8 Finland

Other disease of blood and blood-forming organs, Polycythaemia, secondary

+∞

43.8

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

5.0

43.1

143

291

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

4.1

43.0

173

427

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

10.5

42.9

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

42.9

1270

8404

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

3.4

42.9

215

640

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

12.7

42.8

D76.1

ICD-10 Finland

Haemophagocytic lymphohistiocytosis

+∞

42.7

N05AH03

ATC

olanzapine; systemic

2.2

42.4

476

2272

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

42.3

666

3637

A02BC01

ATC

omeprazole; systemic

1.5

42.3

2082

15454

A05AA02

ATC

ursodeoxycholic acid; oral

3.9

42.3

180

468

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.2

41.7

224

702

A07AA02

ATC

nystatin; oral

2.1

41.7

519

2589

D46.9

ICD-10 Finland

Myelodysplastic syndrome, unspecified

9.2

41.6

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.9

41.6

258

893

HAB40

NOMESCO Finland

Wedge excision of mammary gland

2.2

41.5

427

1956

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

17.0

41.4

XW4XT

NOMESCO Finland

Biopsy of other inner organ with radiological guidance guidance

17.0

41.4

TQW20

NOMESCO Finland

Tatoe

4.8

41.4

143

304

C07AB07

ATC

bisoprolol; oral

1.4

41.1

3496

28637

L01XE01

ATC

[U] imatinib; oral

14.4

41.1

ED1AA

NOMESCO Finland

Mandipular X-ray examination

7.2

41.1

102

144

192

Kela drug reimbursment

Fulvestrant

9.0

40.9

L01BB05

ATC

fludarabine; systemic

21.6

40.8

128

Kela drug reimbursment

Cancers of female genital organs

3.8

40.8

181

488

L01CA04

ATC

vinorelbine; systemic

5.8

40.7

119

209

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

3.8

40.6

178

475

A02BC05

ATC

esomeprazole; systemic

1.4

40.5

3037

24333

WX892

NOMESCO Finland

Monitored bed care

1.9

40.3

611

3291

AA1AD

NOMESCO Finland

CT of head and brain

1.5

40.2

1757

12705

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

40.1

3049

24475

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

5.8

39.7

115

200

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

12.1

39.7

D76.3

ICD-10 Finland

Other histiocytosis syndromes

+∞

39.6

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

3.3

39.4

211

660

E0000UV

ATC

1.4

39.4

2938

23484

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

39.3

1309

8900

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

12.5

39.3

R79.8

ICD-10 Finland

Other specified abnormal findings of blood chemistry

6.8

39.1

101

151

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.5

39.0

315

1278

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.9

38.7

165

430

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.6

38.6

288

1119

L03AB04

ATC

interferon alfa-2a; parenteral

17.1

38.4

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

38.1

2080

15697

A28

ICPC

Limited function/disability NOS

1.6

38.1

1036

6688

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.2

38.0

204

640

P01AB01

ATC

metronidazole; oral, rectal

1.4

37.9

2922

23444

SPAT1254

SPAT

Administration of medicine

1.6

37.6

1076

7038

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

4.2

37.4

147

356

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

3.0

37.4

221

741

L02BA03

ATC

fulvestrant; parenteral

7.9

37.1

110

C91.9

ICD-10 Finland

Lymphoid leukaemia, unspecified

17.7

37.0

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

6.1

36.9

103

171

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

3.1

36.9

209

681

D47.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified

10.4

36.8

A79

ICPC

Malignancy NOS

4.1

36.8

146

357

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.7

36.7

256

955

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.6

36.5

170

478

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

3.9

36.5

157

413

9863/3-C42.1

ICD-O-3

Chronic myeloid leukemia, NOS, of bone marrow

29.0

36.4

J05AB01

ATC

aciclovir; systemic

1.5

36.3

1524

10892

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

36.3

716

4210

H02AB07

ATC

prednisone; oral

1.6

36.2

1075

7091

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

36.2

389

1820

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

26.4

36.2

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.1

36.1

419

2028

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

35.9

451

2256

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.1

35.7

445

2217

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.4

35.7

306

1283

J02AC03

ATC

voriconazole; systemic

15.2

35.6

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

35.3

1284

8892

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

12.7

35.1

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

35.0

983

6388

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

4.3

34.9

132

309

L04AX01

ATC

azathioprine; systemic

2.2

34.8

366

1694

390

Kela drug reimbursment

Ibrutinib

20.1

34.7

R79.9

ICD-10 Finland

Abnormal finding of blood chemistry, unspecified

6.3

34.5

148

R06AE07

ATC

cetirizine; oral

1.3

34.4

3197

26314

28998

ICD-8 Finland

Other disease of blood and blood-forming organs, Alii definiti

+∞

34.4

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

10.2

34.1

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

5.1

34.1

110

218

C03DA01

ATC

spironolactone; oral

1.7

33.9

766

4690

WX002

NOMESCO Finland

Sedation and analgesia

1.5

33.7

1462

10504

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.3

33.7

176

542

9673/3-C42.1

ICD-O-3

Mantle cell lymphoma of bone marrow

45.7

33.7

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

33.5

790

4895

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

5.1

33.5

108

214

B73

ICPC

Leukaemia

21.4

33.4

C50

ICD-10 Finland

Malignant neoplasm of breast

2.9

33.2

206

715

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

3.8

33.2

145

387

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.2

33.1

182

582

174

Kela drug reimbursment

Ruxolitinib

33.2

33.1

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

32.9

883

5667

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

4.8

32.8

111

232

SPAT1262

SPAT

Handing over of treatment supplies

1.5

32.7

1341

9514

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

5.1

32.6

104

204

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

11.2

32.1

J01CA04

ATC

amoxicillin; systemic

1.4

32.1

6309

57757

S18

ICPC

Laceration/cut

1.3

32.0

3086

25457

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

3.6

31.8

149

422

ZX131

NOMESCO Finland

Intrathecal

43.5

31.8

C82.1

ICD-10 Finland

Follicular lymphoma grade II

5.7

31.8

165

SPAT1088

SPAT

Blood transfusion

7.4

31.7

103

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

3.0

31.6

189

641

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

31.5

341

1601

JMA11

NOMESCO Finland

Laparoscopic total splenectomy

16.0

31.5

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.3

31.4

296

1302

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.2

31.3

121

290

1501

Kela drug reimbursment

Palbociclib

7.0

31.3

112

1512

Kela drug reimbursment

Ibrutinib

19.7

31.2

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.8

31.2

549

3109

D61.9

ICD-10 Finland

Aplastic anaemia, unspecified

31.7

31.2

B00.2

ICD-10 Finland

Herpesviral gingivostomatitis and pharyngotonsillitis

9.9

31.2

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

4.7

31.0

108

233

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

31.0

1483

10846

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

2.9

31.0

196

689

3AA02

NOMESCO Finland

70.1

30.9

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.7

30.7

212

785

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

2.8

30.7

201

724

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

8.0

30.6

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

30.5

3119

25901

R03AC02

ATC

salbutamol; inhalant

1.3

30.4

3867

33118

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.9

30.4

189

658

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

11.0

30.4

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.0

30.4

413

2132

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

4.9

30.3

101

208

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

6.4

30.3

128

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

30.2

1160

8102

D76.00

ICD-10 Finland

Eosinophilic granuloma

+∞

30.2

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

30.1

808

5180

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

30.1

363

1783

TAB00

NOMESCO Finland

Lumbar puncture

2.1

30.1

340

1626

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

3.2

30.1

163

517

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

30.0

518

2913

ZX090

NOMESCO Finland

Other technic of radiotherapy

2.5

29.9

244

996

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.4

29.9

151

454

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

29.9

976

6574

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.7

29.8

134

367

RS220

NOMESCO Finland

3.5

29.8

141

403

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

4.7

29.8

103

221

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

4.1

29.6

118

291

SPAT1263

SPAT

Sampling

1.3

29.5

3131

26100

L02BG03

ATC

anastrozole; oral

3.2

29.3

159

505

J02AC01

ATC

fluconazole; systemic

1.3

29.2

2800

22994

L01EA01

ATC

imatinib; oral (bcr-abl tyrosine kinase inhibitors)

18.1

29.1

WW409

NOMESCO Finland

Other aferesis

10.1

29.0

C91.4

ICD-10 Finland

Hairy-cell leukaemia

31.8

29.0

374

Kela drug reimbursment

Ruxolitinib

31.8

29.0

B01AB04

ATC

dalteparin; parenteral

2.0

29.0

382

1949

FM1FN

NOMESCO Finland

Heart function isotope examination

5.7

28.9

148

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.5

28.8

139

404

N05AH04

ATC

quetiapine; oral

1.5

28.7

1096

7639

A03

ICPC

Fever

1.5

28.6

1050

7259

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

28.5

2653

21674

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

29.3

28.4

TPX15

NOMESCO Finland

Removal of vascular injection port

6.5

28.3

114

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

9.9

28.3

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.3

28.2

272

1211

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

5.2

28.2

173

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

3.4

28.2

140

416

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.5

28.2

234

966

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

28.2

528

3051

28999

ICD-8 Finland

Other disease of blood and blood-forming organs, Other and unspecified

+∞

28.1

2880B

ICD-9 Finland

Diseases of white blood cells, Agranulocytosis[AGRANULOCYTOSIS, E MEDICAMENTIS]

+∞

28.1

D72.0

ICD-10 Finland

Genetic anomalies of leukocytes

+∞

28.1

TK800

NOMESCO Finland

Hemodialysis

2.8

28.1

186

675

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

3.2

28.1

154

493

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.5

28.0

219

876

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

11.1

27.9

ZXA00

NOMESCO Finland

Right side

1.4

27.7

1954

15275

R18

ICD-10 Finland

Ascites

3.1

27.7

160

531

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

3.2

27.5

151

484

L28

ICPC

Limited function/disability (L)

1.5

27.4

1065

7447

N06AX16

ATC

venlafaxine; oral

1.5

27.4

949

6470

L01XE33

ATC

[U] palbociclib; oral

8.4

27.1

L01XE27

ATC

[U] ibrutinib; oral

21.8

26.9

Z51.0

ICD-10 Finland

Radiotherapy session

3.5

26.8

126

359

B02.9

ICD-10 Finland

Zoster without complication

1.9

26.6

410

2218

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

26.6

558

3337

9940/3-C42.1

ICD-O-3

Hairy cell leukemia, NOS, of bone marrow

34.1

26.4

ZZF00

NOMESCO Finland

Graft of adipose tissue

4.4

26.3

223

JAH00

NOMESCO Finland

Laparotomy

2.5

26.3

217

892

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

26.2

281

1315

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

26.1

316

1558

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.0

26.1

357

1847

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

4.5

26.0

212

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

19.6

26.0

R4190

NOMESCO Finland

Nutritional therapy

2.2

26.0

262

1193

L01AA02

ATC

chlorambucil; oral

9.2

25.8

N06AX11

ATC

mirtazapine; oral

1.3

25.8

2215

17819

A06AH03

ATC

naloxegol; oral

3.8

25.7

112

300

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

25.7

580

3542

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

11.8

25.6

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

25.6

1167

8424

B72

ICPC

Hodgkin Lymphoma

20.1

25.6

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

4.5

25.5

207

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.3

25.4

239

1054

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

25.2

460

2636

316

Kela drug reimbursment

Imatinib

17.8

25.2

ZXA05

NOMESCO Finland

Left side

1.4

25.2

1811

14168

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

25.2

1224

8946

A07AA09

ATC

vancomycin; oral

3.4

25.0

124

369

394

Kela drug reimbursment

Palbociclib

6.5

25.0

100

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

25.0

3327

28404

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

6.0

25.0

115

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.7

24.9

170

629

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

7.9

24.8

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

17.0

24.8

R03BB04

ATC

tiotropium bromide; inhalant

1.6

24.6

691

4476

C95.0

ICD-10 Finland

Acute leukaemia of unspecified cell type

15.4

24.5

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

2.9

24.5

149

514

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

24.4

527

3179

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.0

24.4

144

487

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

2.1

24.3

298

1477

WF002

NOMESCO Finland

Radical radiotherapy

1.9

24.3

355

1883

B01AA03

ATC

warfarin; systemic

1.4

24.2

1336

9984

K92.1

ICD-10 Finland

Melaena

1.9

24.1

355

1887

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.8

24.1

153

543

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

24.0

1209

8886

D71

ICD-10 Finland

Functional disorders of polymorphonuclear neutrophils

+∞

24.0

L01AA01

ATC

cyclophosphamide; systemic

6.9

23.9

6BA02

NOMESCO Finland

7.8

23.9

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

5.4

23.8

134

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

23.7

828

5649

122

Kela drug reimbursment

Aplastic anaemia

31.1

23.7

L01XE18

ATC

[U] ruxolitinib; oral

31.1

23.7

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

2.8

23.6

153

548

L01EJ01

ATC

ruxolitinib; oral

41.5

23.6

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.1

23.5

131

426

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

3.6

23.4

107

299

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

23.4

1013

7231

S97

ICPC

Chronic ulcer skin

1.8

23.3

380

2098

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

4.6

23.3

181

N05BA01

ATC

diazepam; systemic, rectal

1.5

23.1

929

6531

3AA13

NOMESCO Finland

8.3

23.0

D73.3

ICD-10 Finland

Abscess of spleen

+∞

22.9

120

Kela drug reimbursment

Hypogammaglobulinaemia

11.7

22.9

5BA08

NOMESCO Finland

5.3

22.8

133

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

7.8

22.6

TGD00

NOMESCO Finland

Needle biopsy of lung

5.5

22.5

123

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

22.5

463

2752

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.4

22.4

187

776

R60.0

ICD-10 Finland

Localized oedema

1.5

22.4

744

5014

WW306

NOMESCO Finland

Transfer of stem cells from foreign registered donator

32.3

22.4

N18.8

ICD-10 Finland

Other chronic renal failure

2.3

22.4

202

874

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

7.6

22.2

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.3

22.2

114

350

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.0

22.1

281

1412

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

3.5

22.0

103

295

B28

ICPC

Limited function/disability (B)

6.3

21.9

D76.01

ICD-10 Finland

Histiocytosis X (chronic)

+∞

21.9

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.7

21.8

441

2610

R71

ICD-10 Finland

Abnormality of red blood cells

9.6

21.7

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

5.7

21.6

109

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.7

21.6

463

2784

1BC07

NOMESCO Finland

115.3

21.6

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.0

21.6

288

1480

B34.9

ICD-10 Finland

Viral infection, unspecified

2.3

21.5

193

833

D46.2

ICD-10 Finland

Refractory anaemia with excess of blasts [RAEB]

15.3

21.4

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

21.3

623

4073

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

7.9

21.1

9835/3-C42.1

ICD-O-3

Precursor cell lymphoblastic leukemia, NOS, of bone marrow

14.6

21.1

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.0

21.0

215

H02AB04

ATC

methylprednisolone; systemic

1.4

21.0

997

7238

B03XA01

ATC

erythropoietin; parenteral

4.1

21.0

201

JAH01

NOMESCO Finland

Laparoscopy

1.9

20.9

301

1587

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

20.9

501

3110

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

20.8

440

2639

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.6

20.6

151

582

TQW99

NOMESCO Finland

Other minor procedure on skin

1.8

20.6

338

1871

M05BA04

ATC

alendronic acid; oral

1.6

20.6

539

3427

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

4.0

20.6

205

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

20.5

1087

8050

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

3.1

20.4

114

373

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

20.3

636

4229

N05CD07

ATC

temazepam; oral

1.5

20.2

826

5816

P01BA02

ATC

hydroxychloroquine; oral

1.6

20.2

565

3652

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.5

20.2

639

4256

121

Kela drug reimbursment

Severe hypofunction of sexual glands

2.6

20.2

152

597

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

20.1

266

1363

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

3.0

20.0

116

388

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

4.2

20.0

186

WNF00

NOMESCO Finland

Infection source and contact determination

5.7

20.0

100

N05AD01

ATC

haloperidol; systemic

2.1

19.9

217

1026

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.6

19.9

256

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

6.6

19.9

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

6.4

19.8

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.5

19.8

158

643

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

7.1

19.7

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

19.6

2661

22571

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

19.6

483

3020

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

19.6

1818

14687

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.4

19.6

291

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.1

19.5

108

351

WW402

NOMESCO Finland

Leucoferesis

12.1

19.5

XX7BT

NOMESCO Finland

Radioactive phosphorus therapy

40.1

19.5

WE300

NOMESCO Finland

Profylactive therapy of malignancy with biomoidiers

21.6

19.4

N05AA02

ATC

levomepromazine; systemic

1.9

19.4

293

1575

ZX114

NOMESCO Finland

Intramuscular

2.8

19.4

123

437

188

Kela drug reimbursment

Psychosis requiring demanding treatment

3.3

19.3

289

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

8.8

19.3

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

2.8

19.1

126

458

R50.8

ICD-10 Finland

Other specified fever

4.7

19.0

140

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.2

18.9

190

867

ZX100

NOMESCO Finland

Oral

2.9

18.9

117

410

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

2.6

18.9

142

559

PJW99

NOMESCO Finland

Other operation on lymphatic system

5.5

18.9

103

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.6

18.8

513

3293

J01AA02

ATC

doxycycline; systemic

1.2

18.8

5930

55133

B74

ICPC

Malignant neoplasm blood other

9.1

18.8

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

18.7

1231

9441

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

4.0

18.7

184

D64.8

ICD-10 Finland

Other specified anaemias

2.8

18.7

120

430

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.3

18.7

168

726

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.4

18.7

152

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

4.4

18.7

152

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

4.8

18.7

130

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.0

18.7

254

1314

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.5

18.6

147

595

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

4.0

18.6

190

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

18.6

437

2700

N03AG01

ATC

valproic acid; systemic, rectal

1.7

18.6

393

2356

1CX01

NOMESCO Finland

9.3

18.5

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.4

18.5

156

655

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.3

18.3

163

702

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.2

18.2

196

922

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

9.8

18.1

EBA10

NOMESCO Finland

Surgical removal of tooth

1.5

18.0

700

4880

J02AC04

ATC

posaconazole; systemic

32.9

17.9

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.4

17.9

145

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

3.4

17.9

253

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

17.8

386

2329

N04AA02

ATC

biperiden; systemic

2.4

17.8

150

627

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

17.8

2788

23983

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.1

17.8

308

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.5

17.8

583

3914

N05AX12

ATC

aripiprazole; systemic

2.0

17.7

236

1211

A10AE04

ATC

insulin glargine; parenteral

1.5

17.7

603

4084

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.6

17.7

431

2687

UKC02

NOMESCO Finland

Cystoscopy

1.4

17.7

1048

7898

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

3.5

17.6

235

B04

ICPC

Blood symptom/complaint

5.1

17.6

108

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

3.6

17.6

225

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.5

17.6

143

588

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

15.6

17.4

N28.0

ICD-10 Finland

Ischaemia and infarction of kidney

8.0

17.4

L04AA01

ATC

[U] ciclosporin; systemic

2.6

17.3

127

492

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.4

17.3

244

-50

ICPC

Medication/prescr/renewal

1.8

17.3

296

1665

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

4.1

17.2

165

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

2.6

17.2

124

478

WX702

NOMESCO Finland

Supraglottic ventilation device

1.7

17.1

352

2093

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

3.8

17.1

190

3AC01

NOMESCO Finland

3.1

17.1

311

1XC03

NOMESCO Finland

5.7

17.1

E87.6

ICD-10 Finland

Hypokalaemia

2.0

17.1

207

1024

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

17.1

836

6093

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

6.3

17.1

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.3

17.0

165

741

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.3

17.0

152

658

R04.0

ICD-10 Finland

Epistaxis

1.6

17.0

457

2925

J94.8

ICD-10 Finland

Other specified pleural conditions

2.7

17.0

117

437

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.3

16.9

152

659

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

9.0

16.8

152

Kela drug reimbursment

Nilotinib

21.9

16.8

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.5

16.8

229

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

5.1

16.7

102

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.0

16.7

214

1085

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

3.5

16.7

230

HAB99

NOMESCO Finland

Other partial excision of mammary gland

2.2

16.7

173

800

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

4.6

16.7

124

ZX095

NOMESCO Finland

Combined chemoradiotherapy

4.0

16.6

166

B01AC14

ATC

[U] anagrelide; oral

90.2

16.5

D07AC01

ATC

betamethasone; topical

1.2

16.5

2335

19810

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

16.5

2110

17697

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

3.2

16.4

265

L01XX52

ATC

venetoclax; oral

17.9

16.4

Z94.0

ICD-10 Finland

Kidney transplant status

3.1

16.3

294

A02BC03

ATC

lansoprazole; oral

1.3

16.3

1996

16654

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.2

16.3

163

744

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

3.9

16.3

174

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.0

16.2

301

TQW80

NOMESCO Finland

Local dermatologic skincare

2.1

16.2

185

897

Z94.2

ICD-10 Finland

Lung transplant status

9.2

16.1

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

12.8

16.1

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

16.1

463

3016

L01EL01

ATC

ibrutinib; oral

16.7

16.0

9680/3-C42.1

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of bone marrow

24.5

16.0

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.2

15.9

156

707

E000001

ATC

1.3

15.9

1351

10747

ZXA10

NOMESCO Finland

Bilateral

1.3

15.9

1246

9798

L01EF01

ATC

palbociclib; oral

6.9

15.8

J96.1

ICD-10 Finland

Chronic respiratory failure

2.3

15.7

140

604

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

15.7

762

5541

WX882

NOMESCO Finland

High dependency care

2.0

15.7

203

1031

2888A

ICD-9 Finland

Diseases of white blood cells, Other specified disease of white blood cells[LEUCOCYTOSIS]

+∞

15.6

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

2.3

15.6

146

647

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

2.0

15.6

205

1050

163

Kela drug reimbursment

Abiraterone and enzalutamide

3.4

15.6

222

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

3.3

15.6

233

ZZR10

NOMESCO Finland

Flap of skin and muscle

3.4

15.5

223

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

15.5

1483

11985

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.9

15.5

227

1211

399

Kela drug reimbursment

Venetoclax

13.7

15.5

A29

ICPC

General symptom/complaint other

1.4

15.4

694

4978

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

1.9

15.4

214

1122

HAE99

NOMESCO Finland

Other reconstruction of breast

3.5

15.4

209

T90

ICPC

Diabetes non-insulin dependent

1.3

15.3

1495

12112

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

4.0

15.2

155

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.7

15.2

349

2145

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.8

15.2

267

1516

C83.00

ICD-10 Finland

Lymphocytic lymphoma

5.9

15.2

Z71.8

ICD-10 Finland

Other specified counselling

1.3

15.1

1546

12597

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

3.7

15.1

176

J01DA01

ATC

[U] cefalexin; systemic

1.2

15.1

4560

41685

9945/3-C42.1

ICD-O-3

Chronic myelomonocytic leukemia, NOS, of bone marrow

45.0

15.0

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

15.0

586

4084

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

3.3

15.0

234

D69.0

ICD-10 Finland

Allergic purpura

4.1

15.0

143

A07EA06

ATC

budesonide; oral, local oral

1.9

15.0

225

1212

D69.4

ICD-10 Finland

Other primary thrombocytopenia

13.9

15.0

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.8

14.9

264

1501

XX9CD

NOMESCO Finland

Very extensive complementary CT

10.0

14.9

N05AF05

ATC

zuclopenthixol; systemic

2.9

14.8

297

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

14.8

1626

13366

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

14.8

304

1811

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.7

14.8

356

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

14.8

720

5238

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.5

14.7

442

2910

J45.1

ICD-10 Finland

Nonallergic asthma

1.5

14.7

452

2991

L03AA04

ATC

8.2

14.7

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

14.7

471

3149

L02BB04

ATC

enzalutamide; oral

3.7

14.6

176

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.7

14.6

105

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

21.0

14.6

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

14.6

1946

16362

D73.2

ICD-10 Finland

Chronic congestive splenomegaly

+∞

14.6

D75

ICD-10 Finland

Other diseases of blood and blood-forming organs

80.2

14.6

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

14.6

732

9646

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

5.0

14.5

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

4.0

14.5

143

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

2.8

14.5

341

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.9

14.4

214

1148

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

14.4

534

3685

N05CF02

ATC

zolpidem; oral

1.3

14.4

1133

8904

K29.7

ICD-10 Finland

Gastritis, unspecified

1.8

14.4

226

1238

C83.89

ICD-10 Finland

Other types of diffuse non-Hodgkin's lymphoma

12.5

14.3

M10.9

ICD-10 Finland

Gout, unspecified

1.6

14.3

397

2562

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.1

14.3

157

749

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

3.1

14.3

243

L02AE03

ATC

goserelin; implant

2.8

14.3

328

L01XX28

ATC

[D] imatinib; oral

27.2

14.2

150

Kela drug reimbursment

Dasatinib

19.1

14.2

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.9

14.1

284

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

14.1

376

2406

SPAT1153

SPAT

Removal of sutures

1.2

14.1

2203

18841

A01AB09

ATC

miconazole; local oral

1.5

14.1

562

3936

SPAT1229

SPAT

Assessment of need for aid

1.5

14.0

502

3436

UDC00

NOMESCO Finland

Ear microscopy

1.5

14.0

458

3074

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.6

14.0

348

2184

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

8.0

14.0

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

14.0

412

2697

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

14.0

2763

24196

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.3

14.0

125

542

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

8.4

13.9

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.5

13.9

461

3102

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

13.9

353

2231

R31

ICD-10 Finland

Unspecified haematuria

1.4

13.8

608

4336

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

13.8

451

3026

R4120

NOMESCO Finland

Occupational therapy

1.6

13.8

404

2645

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.5

13.8

109

444

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.7

13.7

353

F20.10

ICD-10 Finland

Raise schizophrenia continuously

4.9

13.6

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.9

13.6

201

1075

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

4.6

13.6

100

C84.59

ICD-10 Finland

Other and unspecified T-cell lymphomas

12.0

13.5

GEA00

NOMESCO Finland

Mediastinoscopy

4.5

13.5

105

N05AX08

ATC

risperidone; systemic

1.5

13.5

455

3075

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

5.7

13.5

KFC00

NOMESCO Finland

Unilateral orchiectomy

3.9

13.5

138

UJF92

NOMESCO Finland

Capsular endoscopy

2.2

13.5

138

638

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

10.9

13.5

N03AX09

ATC

lamotrigine; oral

1.7

13.5

272

1612

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

13.5

522

3637

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

4.5

13.4

106

ZZQ70

NOMESCO Finland

Free microvascular graft of lymph nodes

12.8

13.4

J32.4

ICD-10 Finland

Chronic pansinusitis

2.5

13.3

103

415

JAL30

NOMESCO Finland

Omentectomy

2.8

13.3

308

L01XE06

ATC

[U] dasatinib; systemic

21.1

13.3

RS221

NOMESCO Finland

2.5

13.3

106

435

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

8.1

13.2

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.9

13.2

206

1123

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

13.2

756

5655

WX872

NOMESCO Finland

Intensive care

1.6

13.2

320

1998

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

13.2

1760

14775

N05AF03

ATC

chlorprothixene; systemic

2.0

13.2

175

902

I81

ICD-10 Finland

Portal vein thrombosis

5.0

13.1

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.2

13.1

209

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.0

13.1

166

840

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

13.1

523

3660

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

2.1

13.1

140

660

N03AE01

ATC

clonazepam; systemic

1.6

13.1

368

2388

1AA09

NOMESCO Finland

12.1

13.1

R93.5

ICD-10 Finland

Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum

2.6

13.0

365

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.6

13.0

313

1952

N05AA01

ATC

chlorpromazine; systemic, rectal

2.5

13.0

101

410

2AX04

NOMESCO Finland

16.7

13.0

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

4.5

12.9

101

9811/3-C42.1

ICD-O-3

B lymphoblastic leukemia/lymphoma, NOS, of bone marrow

28.4

12.9

B29

ICPC

Lymph/immune mech sympt/complt other

4.8

12.9

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

12.9

476

3284

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

12.9

1100

8739

XX1AD

NOMESCO Finland

Other CT-examination

3.5

12.8

170

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

4.2

12.8

116

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.6

12.7

358

D58.2

ICD-10 Finland

Other haemoglobinopathies

14.0

12.7

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

2.4

12.7

106

447

B37.08

ICD-10 Finland

Other candidal stomatitis

3.3

12.7

188

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.9

12.6

193

1045

J96.0

ICD-10 Finland

Acute respiratory failure

2.7

12.6

328

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

3.8

12.6

137

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

3.7

12.6

142

J01FA06

ATC

roxithromycin; oral

1.2

12.6

2745

24201

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.0

12.5

159

804

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

2.1

12.5

137

655

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.5

12.5

406

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.4

12.5

641

4706

2883X

ICD-9 Finland

Diseases of white blood cells, Eosinophilia[EOSINOPHILIA, NUD]

+∞

12.5

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.2

12.5

126

581

L01BB02

ATC

mercaptopurine; oral

2.8

12.4

292

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

3.6

12.4

154

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.1

12.4

131

616

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.6

12.4

320

2031

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.6

12.4

348

2255

E89.4

ICD-10 Finland

Postprocedural ovarian failure

13.2

12.4

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.9

12.4

167

868

N03AX12

ATC

gabapentin; oral

1.3

12.4

989

7782

A11CC03

ATC

alfacalcidol; systemic

2.0

12.4

149

740

D07AA02

ATC

hydrocortisone; topical

1.3

12.4

834

6405

R05

ICD-10 Finland

Cough

1.3

12.3

1243

10084

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

12.3

346

2244

R51.80

ICD-10 Finland

Headache

1.3

12.3

892

6925

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

2.3

12.3

112

494

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

12.3

1546

12884

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

5.0

12.2

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.1

12.2

130

615

SPAT1260

SPAT

Consultation of another employee

1.3

12.2

1160

9344

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

4.5

12.2

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

12.1

392

2627

C84.49

ICD-10 Finland

Peripheral T-cell lymphoma, unspecified cell type

15.9

12.1

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

12.1

507

3586

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

12.1

719

5411

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

3.3

12.1

179

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

4.2

12.1

104

C09AA05

ATC

ramipril; oral

1.2

12.0

1570

13129

R04.2

ICD-10 Finland

Haemoptysis

1.8

12.0

209

1185

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

4.1

12.0

109

JAH21

NOMESCO Finland

Staging laparoscopy

26.7

12.0

B84

ICPC

Unexplained abnormal white cells

26.7

12.0

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.7

12.0

267

1631

M79.6

ICD-10 Finland

Pain in limb

1.2

12.0

2372

20697

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.0

12.0

158

815

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

4.1

12.0

114

JN5AN

NOMESCO Finland

Total body isotope imaging

11.0

12.0

H03AA01

ATC

levothyroxine sodium; systemic

1.2

12.0

1516

12635

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.1

12.0

137

666

C83.71

ICD-10 Finland

Burkitt's tumour

21.3

12.0

SPAT1211

SPAT

Application of soft bandage

1.4

12.0

566

4092

K92.0

ICD-10 Finland

Haematemesis

2.0

12.0

146

729

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

11.9

856

6629

N05AN01

ATC

lithium; oral

2.0

11.9

150

758

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

11.9

436

3001

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

2.6

11.9

318

SPAT1104

SPAT

Monitoring of emergency patient

1.5

11.8

414

2824

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.3

11.8

105

454

5AB14

NOMESCO Finland

7.9

11.8

N02AA01

ATC

morphine; systemic, rectal

2.6

11.8

337

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

7.0

11.8

L02BX03

ATC

abiraterone; oral

3.8

11.8

126

D07AB08

ATC

desonide; topical

1.4

11.8

655

4876

T80.8

ICD-10 Finland

Other complications following infusion, transfusion and therapeutic injection

8.9

11.7

NJ3DG

NOMESCO Finland

Very extensive MRI examination of extremities with high intensity magnet

8.9

11.7

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.7

11.7

250

1508

L01BC59

ATC

trifluridine, combinations; systemic

7.3

11.7

JAL00

NOMESCO Finland

Biopsy of peritoneum

4.1

11.6

108

N03AX14

ATC

levetiracetam; systemic

1.9

11.6

165

876

JFB00

NOMESCO Finland

Partial resection of small intestine

2.2

11.6

113

515

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

18.9

11.6

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.3

11.5

106

467

E86

ICD-10 Finland

Volume depletion

2.0

11.5

141

708

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

11.5

302

1928

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

8.6

11.5

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.3

11.5

106

470

K02.1

ICD-10 Finland

Caries of dentine

1.2

11.5

3914

35783

2898X

ICD-9 Finland

Other diseases of blood and blood-forming organs, Other specified diseases of blood and blood-forming organs

+∞

11.5

2890X

ICD-9 Finland

Other diseases of blood and blood-forming organs, Polycythaemia, secondary[ERYTHROCYTOSIS SECUNDARIA, NUD]

+∞

11.5

N30.0

ICD-10 Finland

Acute cystitis

1.3

11.5

835

6481

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.6

11.4

311

2001

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

1.9

11.4

159

835

PG1BD

NOMESCO Finland

Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft

13.6

11.4

-44

ICPC

Preventive immunization/medic

1.4

11.4

514

3689

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

1.7

11.4

252

1537

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.6

11.4

259

1594

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

11.4

299

1909

J01FA10

ATC

azithromycin; systemic

1.2

11.3

4047

37122

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.1

11.3

123

587

9989/3-C42.1

ICD-O-3

Myelodysplastic syndrome, NOS, of bone marrow

7.8

11.3

R02

ICPC

Shortness of breath/dyspnoea

1.3

11.3

737

5631

9680/3-C16.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of stomach, NOS

35.0

11.3

C81.7

ICD-10 Finland

Other classical Hodgkin lymphoma

10.5

11.2

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.5

11.2

336

E83.50

ICD-10 Finland

Hypercalcemia

2.4

11.2

373

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.1

11.2

125

605

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

7.2

11.2

KBV00

NOMESCO Finland

Insertion of stent into ureter

3.6

11.2

137

D40.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Testis

3.8

11.2

122

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

5.3

11.1

9983/3-C42.1

ICD-O-3

Myelodysplastic syndrome with excess blasts of bone marrow

25.0

11.1

9663/3-C77.9

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS

12.7

11.1

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

6.8

11.1

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

11.1

1822

15599

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.2

11.1

175

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.7

11.1

234

1411

N06AB04

ATC

citalopram; systemic

1.2

11.1

1364

11328

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

11.0

1794

15338

Z94.4

ICD-10 Finland

Liver transplant status

4.6

11.0

N05AB03

ATC

perphenazine; systemic, rectal

1.7

11.0

216

1273

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.7

11.0

129

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

3.7

11.0

129

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.4

11.0

365

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

2.7

10.9

256

D86.0

ICD-10 Finland

Sarcoidosis of lung

2.4

10.9

358

X21

ICPC

Breast sympt/compl female other

2.1

10.9

117

554

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

10.9

522

3790

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.5

10.9

341

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.4

10.9

378

P72

ICPC

Schizophrenia

2.2

10.8

112

523

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.6

10.8

271

1707

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.6

10.8

263

1645

F20.1

ICD-10 Finland

Hebephrenic schizophrenia

7.8

10.8

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

7.8

10.8

D47.0

ICD-10 Finland

Histiocytic and mast cell tumours of uncertain and unknown behaviour

15.5

10.8

S29

ICPC

Skin symptom/complaint other

1.3

10.8

1057

8540

1XX32

NOMESCO Finland

8.2

10.8

B59

ICD-10 Finland

Pneumocystosis

10.5

10.7

GDG10

NOMESCO Finland

Bilateral transplantation of lung

8.8

10.7

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

2.0

10.7

128

637

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

10.7

502

3630

D61.0

ICD-10 Finland

Constitutional aplastic anaemia

17.8

10.7

ZX110

NOMESCO Finland

Intracutaneous

6.1

10.7

WX400

NOMESCO Finland

Inhalation anesthesy

1.6

10.7

263

1650

D68.8

ICD-10 Finland

Other specified coagulation defects

2.7

10.7

271

JJC00

NOMESCO Finland

Allogenic transplantation of liver

5.8

10.7

SPAT1301

SPAT

No procedures

1.2

10.7

2131

18579

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

2.7

10.6

272

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.8

10.6

242

I50.0

ICD-10 Finland

Congestive heart failure

1.5

10.6

387

2662

1518

Kela drug reimbursment

12.9

10.6

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

10.6

473

3385

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.4

10.6

577

4280

A07EC02

ATC

mesalazine; oral, rectal

1.5

10.6

326

2164

TJA10

NOMESCO Finland

Laparocentesis

5.1

10.6

XX1XN

NOMESCO Finland

Other isotope examination

2.8

10.6

227

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

4.1

10.6

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

3.2

10.5

171

E29.1

ICD-10 Finland

Testicular hypofunction

2.8

10.5

244

NF3AA

NOMESCO Finland

Femur X-ray examination

2.0

10.5

122

600

B02BX05

ATC

eltrombopag; oral

11.2

10.5

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

10.5

578

4293

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.6

10.5

258

1620

V03AG01

ATC

sodium cellulose phosphate; systemic

8.5

10.5

D69.1

ICD-10 Finland

Qualitative platelet defects

8.5

10.5

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.2

10.5

1222

10075

I50.1

ICD-10 Finland

Left ventricular failure

1.6

10.4

254

1589

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

10.4

1695

14482

9831/3-C42.1

ICD-O-3

T-cell large granular lymphocytic leukemia of bone marrow

110.1

10.4

2387X

ICD-9 Finland

Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[STATUS LYMPHO- ET MYELOPROLIFERATIVUS NUD]

110.1

10.4

D708

ICD-10 Finland

+∞

10.4

D74.9

ICD-10 Finland

Methaemoglobinaemia, unspecified

+∞

10.4

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

4.4

10.4

101

Kela drug reimbursment

Anterior pituitary hypofunction

3.3

10.4

157

SPAT1109

SPAT

Analgesia with portable analgesic pump

3.2

10.3

168

C84.51

ICD-10 Finland

Other and unspecified T-cell lymphomas

16.0

10.3

X58

ICD-10 Finland

Exposure to other specified factors

1.3

10.3

824

6477

C93.1

ICD-10 Finland

Chronic myelomonocytic leukaemia

32.5

10.3

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

3.8

10.3

111

E000006

ATC

1.4

10.3

434

3073

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.7

10.3

204

1208

L02AE02

ATC

leuprorelin; implant, parenteral

1.6

10.3

257

1622

C01AA05

ATC

digoxin; systemic

1.4

10.2

436

3097

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

3.2

10.2

164

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.0

10.2

130

664

C08CA01

ATC

amlodipine; oral

1.2

10.2

2315

20406

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

1.9

10.1

153

833

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

6.2

10.1

R84

ICPC

Malignant neoplasm bronchus/lung

4.2

10.1

XFE00

NOMESCO Finland

Epicardial ultrasonography

1.9

10.1

150

809

R03AK08

ATC

formoterol and beclometasone; inhalant

1.7

10.1

224

1371

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

10.1

271

1744

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.7

10.0

210

1263

SPAT1240

SPAT

Therapeutic discussion

1.4

10.0

593

4460

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.0

10.0

131

676

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.5

10.0

308

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.3

10.0

845

6699

WA010

NOMESCO Finland

Adjuvant whole body radiotherapy

40.1

10.0

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

5.1

10.0

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.5

9.9

320

2145

R13

ICD-10 Finland

Dysphagia

1.5

9.9

374

2591

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

3.6

9.9

120

RF210

NOMESCO Finland

1.8

9.9

170

964

L04.0

ICD-10 Finland

Acute lymphadenitis of face, head and neck

2.7

9.9

243

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.6

9.9

240

1504

153

Kela drug reimbursment

Lenalidomid

3.5

9.9

126

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

1.9

9.8

140

744

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

3.2

9.8

158

K12.10

ICD-10 Finland

Stomatitis NOS

3.6

9.8

121

A02BA02

ATC

ranitidine; systemic

1.2

9.8

1256

10459

C92.4

ICD-10 Finland

Acute promyelocytic leukaemia [PML]

26.0

9.8

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

9.8

271

1755

9689/3-C42.2

ICD-O-3

Splenic marginal zone B-cell lymphoma of spleen

20.0

9.8

WX2DD

NOMESCO Finland

Low-dose CT of skeleton in whole body

5.9

9.8

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

4.4

9.8

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.0

9.8

121

613

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

9.7

500

3673

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.8

9.7

172

986

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

1.9

9.7

133

699

WX730

NOMESCO Finland

Conventional respirator

2.1

9.7

104

496

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

6.5

9.7

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.1

9.7

101

475

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.7

9.7

196

1168

ZZA00

NOMESCO Finland

Split skin graft

1.7

9.7

175

1010

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.8

9.7

158

881

K83.0

ICD-10 Finland

Cholangitis

2.3

9.7

378

C92.9

ICD-10 Finland

Myeloid leukaemia, unspecified

13.4

9.6

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.3

9.6

370

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

2.6

9.6

259

C07AB02

ATC

metoprolol; systemic

1.2

9.6

1278

10688

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

5.8

9.6

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

1.5

9.6

367

2550

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

3.2

9.6

150

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.2

9.6

1344

11304

J01FA09

ATC

clarithromycin; systemic

1.2

9.6

2065

18098

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.0

9.6

123

629

R55

ICD-10 Finland

Syncope and collapse

1.3

9.6

641

4916

WX610

NOMESCO Finland

Patient controlled analgesia

3.3

9.6

140

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.0

9.5

123

632

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

1.9

9.5

140

756

9109

FHL

Other measure in this category

6.3

9.5

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

5.0

9.5

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

9.5

896

7198

LCA06

NOMESCO Finland

Biopsy of endometrium

1.3

9.5

663

5114

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

3.1

9.5

157

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

9.5

479

3511

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

3.5

9.5

125

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

3.5

9.5

120

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

3.2

9.5

152

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.1

9.4

454

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

9.4

311

2100

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

3.0

9.4

183

N17.8

ICD-10 Finland

Other acute renal failure

2.5

9.4

293

R01AD12

ATC

fluticasone furoate; nasal

1.2

9.4

1829

15876

324

Kela drug reimbursment

Dasatinib

30.0

9.4

1BC01

NOMESCO Finland

30.0

9.4

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

2.7

9.4

227

2899X

ICD-9 Finland

Other diseases of blood and blood-forming organs, Unspecified diseases of blood and blood-forming organs

+∞

9.4

K12.18

ICD-10 Finland

Other forms of stomatitis

2.8

9.4

198

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

4.3

9.4

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

2.5

9.4

287

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

3.6

9.4

111

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.7

9.3

188

1121

9680/3-C80.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of unknown primary site

12.3

9.3

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

12.3

9.3

D61.1

ICD-10 Finland

Drug-induced aplastic anaemia

21.7

9.3

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.9

9.3

130

688

PJ1AN

NOMESCO Finland

Lymphsystem isotope imaging

5.5

9.3

A08

ICPC

Swelling

1.6

9.3

242

1542

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

9.3

422

3035

WF099

NOMESCO Finland

Other radiotherapy

3.2

9.3

143

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.6

9.3

258

1675

XQ800

NOMESCO Finland

Prick test

1.4

9.3

427

3077

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

2.2

9.3

430

H04.10

ICD-10 Finland

Dry eye syndrome

1.3

9.2

583

4433

P99

ICPC

Psychological disorders other

1.9

9.2

139

756

N06AB06

ATC

sertraline; oral

1.3

9.2

620

4756

A04

ICPC

Weakness/tiredness general

1.3

9.2

758

5982

J12.8

ICD-10 Finland

Other viral pneumonia

2.9

9.2

181

V03AE01

ATC

polystyrene sulfonate; oral

2.3

9.2

359

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

3.0

9.2

172

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

9.2

1514

12938

K74.3

ICD-10 Finland

Primary biliary cirrhosis

3.1

9.2

150

N06AX21

ATC

duloxetine; oral

1.3

9.2

637

4909

1CD01

NOMESCO Finland

5.4

9.2

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

2.9

9.2

182

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

4.2

9.1

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.5

9.1

278

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

2.3

9.1

354

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

3.9

9.1

H65.3

ICD-10 Finland

Chronic mucoid otitis media

2.0

9.1

117

601

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

9.0

781

6204

C08CA05

ATC

nifedipine; systemic

1.4

9.0

378

2676

3028

Kela drug reimbursment

Mepolizumab

11.4

9.0

RF120

NOMESCO Finland

2.3

9.0

336

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

4.6

9.0

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

2.5

9.0

280

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

2.9

9.0

185

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.1

9.0

465

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

2.3

9.0

357

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

5.6

9.0

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.5

9.0

300

2029

9875/3-C42.1

ICD-O-3

Chronic myelogenous leukemia, BCR/ABL positive of bone marrow

36.7

9.0

AAA10

NOMESCO Finland

Biopsy through craniotomy

9.0

D80.0

ICD-10 Finland

Hereditary hypogammaglobulinaemia

10.0

9.0

XG474

NOMESCO Finland

Exhalation nntrogen oxide

1.7

9.0

165

955

B81

ICPC

Anaemia vit B12/folate deficiency

1.6

9.0

221

1389

L04AX04

ATC

lenalidomide; oral

3.5

9.0

115

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.4

9.0

420

3035

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

9.0

1530

13111

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

3.9

9.0

E000003

ATC

1.5

8.9

263

1731

SPAT1234

SPAT

Support of social functional capacity

1.5

8.9

287

1926

C88.9

ICD-10 Finland

Malignant immunoproliferative disease, unspecified

18.6

8.9

2AX05

NOMESCO Finland

18.6

8.9

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

4.1

8.9

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

5.0

8.9

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

7.4

8.9

V03AC03

ATC

deferasirox; oral

24.0

8.9

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

8.9

650

5050

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

2.0

8.9

110

559

N19

ICD-10 Finland

Unspecified kidney failure

1.7

8.9

182

1093

9101

FHL

Bone biopsy

5.4

8.9

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.6

8.8

248

1612

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

2.9

8.8

182

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

3.0

8.8

166

HAD99

NOMESCO Finland

Other plastic operation on breast

3.0

8.8

166

N06AB10

ATC

escitalopram; oral

1.2

8.8

1174

9814

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.2

8.8

1006

8272

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.5

8.8

260

1715

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

8.8

394

2830

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

8.6

8.8

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

4.9

8.8

RS121

NOMESCO Finland

3.1

8.8

150

A07EC01

ATC

sulfasalazine; oral, rectal

1.4

8.8

480

3568

XX4BW

NOMESCO Finland

5.6

8.7

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

3.5

8.7

108

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.2

8.7

405

WW304

NOMESCO Finland

Transfer of stem cells from registered domestic donator

50.0

8.7

NH3EA

NOMESCO Finland

Feet X-ray examination with load

1.9

8.7

120

633

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

1.8

8.6

138

767

WX704

NOMESCO Finland

Intubation

1.4

8.6

419

3052

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

2.5

8.6

268

WW400

NOMESCO Finland

Plasmaferesis

5.2

8.6

A09AA02

ATC

multienzymes (lipase, protease etc.)

1.9

8.6

116

610

2951C

ICD-9 Finland

Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]

5.8

8.6

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

5.5

8.6

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.8

8.6

139

776

R03DX09

ATC

mepolizumab; parenteral

11.6

8.6

M05BA06

ATC

ibandronic acid; systemic

1.9

8.5

113

587

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

1.9

8.5

115

602

RD210

NOMESCO Finland

1.9

8.5

119

631

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

8.5

628

4884

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

2.4

8.5

272

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.9

8.5

115

605

D72

ICD-10 Finland

Other disorders of white blood cells

27.5

8.5

SPAT1231

SPAT

Assessment of adjustments needed in living environment

1.9

8.5

117

620

C84.4

ICD-10 Finland

Peripheral T-cell lymphoma, not elsewhere classified

20.0

8.5

2AA01

NOMESCO Finland

20.0

8.5

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

2.7

8.5

212

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

2.0

8.4

478

M05.0

ICD-10 Finland

Felty syndrome

7.3

8.4

9920/3-C42.1

ICD-O-3

Therapy-related myeloid neoplasm of bone marrow

90.1

8.4

A40.1

ICD-10 Finland

Sepsis due to streptococcus, group B

5.6

8.4

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

1.9

8.4

120

640

JFF10

NOMESCO Finland

Loop enterostomy

3.0

8.4

155

N06AA09

ATC

amitriptyline; systemic

1.3

8.4

611

4745

J01CA08

ATC

pivmecillinam; oral

1.2

8.4

2492

22372

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

8.4

1256

10628

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

8.4

294

L01XE08

ATC

[U] nilotinib; oral

12.7

8.4

C62.12

ICD-10 Finland

Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma

7.8

8.3

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

2.6

8.3

232

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

4.8

8.3

D76.2

ICD-10 Finland

Haemophagocytic syndrome, infection-associated

+∞

8.3

D76.0

ICD-10 Finland

Langerhans' cell histiocytosis, not elsewhere classified

+∞

8.3

JM1AT

NOMESCO Finland

Cytology of spleen with ultrasound guidance

+∞

8.3

GDC00

NOMESCO Finland

Lobectomy of lung

3.0

8.3

156

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.4

8.3

288

D69.9

ICD-10 Finland

Haemorrhagic condition, unspecified

3.3

8.3

123

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

2.6

8.3

226

N18.0

ICD-10 Finland

End-stage renal disease

2.3

8.3

308

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

3.7

8.3

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.0

8.3

105

539

R03BA05

ATC

fluticasone; inhalant

1.2

8.3

1112

9304

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

2.4

8.3

289

297

Kela drug reimbursment

10.7

8.3

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.6

8.3

204

1288

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

4.6

8.3

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.3

8.3

488

3672

ZXC40

NOMESCO Finland

Use of ultrasound

2.7

8.3

196

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

2.2

8.2

373

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

2.4

8.2

271

A10AE05

ATC

insulin detemir; parenteral

1.5

8.2

312

2170

Z94.1

ICD-10 Finland

Heart transplant status

4.7

8.2

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.3

8.2

604

4697

I88.9

ICD-10 Finland

Nonspecific lymphadenitis, unspecified

3.3

8.2

119

D83.0

ICD-10 Finland

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

14.5

8.2

D61.3

ICD-10 Finland

Idiopathic aplastic anaemia

14.5

8.2

9698/3-C77.8

ICD-O-3

Follicular lymphoma, grade 3 of lymph nodes of multiple regions

14.5

8.2

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.7

8.2

152

885

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

2.5

8.2

229

306

Kela drug reimbursment

Erythropoietin and darbepoetin

4.2

8.2

I42.0

ICD-10 Finland

Dilated cardiomyopathy

1.7

8.1

150

872

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.1

8.1

3770

34917

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

4.1

8.1

N05AC02

ATC

thioridazine; oral

1.9

8.1

118

636

SPAT1290

SPAT

Preparation of deceased person

5.4

8.1

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

3.9

8.1

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.5

8.1

232

1521

175

Kela drug reimbursment

Deferasirox

33.4

8.1

J17.3

ICD-10 Finland

Pneumonia in parasitic diseases

17.2

8.1

ECB20

NOMESCO Finland

Oral alveoplasty

2.5

8.1

234

Z85.6

ICD-10 Finland

Personal history of leukaemia

11.7

8.1

R52.9

ICD-10 Finland

Pain, unspecified

1.3

8.0

486

3670

D46.0

ICD-10 Finland

Refractory anaemia without ring sideroblasts, so stated

6.8

8.0

R33

ICD-10 Finland

Retention of urine

1.4

8.0

417

3075

JKA20

NOMESCO Finland

Cholecystectomy

1.7

8.0

151

886

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

4.4

8.0

L50.0

ICD-10 Finland

Allergic urticaria

1.7

8.0

142

818

WE100

NOMESCO Finland

Profylactic cytostatic therapy

10.0

8.0

-60

ICPC

Result test/procedure

1.4

8.0

343

2443

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

3.9

8.0

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

2.1

8.0

386

R2110

NOMESCO Finland

Giving the first information

1.4

8.0

395

2885

A91

ICPC

Abnormal result investigation NOS

1.5

8.0

243

1615

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.5

8.0

238

1573

F20

ICD-10 Finland

Schizophrenia

2.9

8.0

159

R5110

SPAT

1.7

7.9

143

827

J01EA01

ATC

trimethoprim; systemic

1.2

7.9

1548

13418

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

7.2

7.9

SPAT1281

SPAT

Other administrative function

1.4

7.9

458

3433

WW200

SPAT

0.7

7.9

356

4778

J04BA02

ATC

dapsone; oral

3.3

7.9

117

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

3.6

7.9

-1

NOMESCO Finland

1.2

7.9

2114

18814

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

1.8

7.9

124

688

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

3.0

7.9

145

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

3.0

7.9

145

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.6

7.9

190

1193

372

Kela drug reimbursment

Idelalisib

13.0

7.9

L04AA10

ATC

sirolimus; oral

13.0

7.9

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.2

7.9

328

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

4.2

7.9

E87.5

ICD-10 Finland

Hyperkalaemia

2.0

7.8

467

J96.9

ICD-10 Finland

Respiratory failure, unspecified

3.1

7.8

129

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.8

7.8

129

726

C56

ICD-10 Finland

Malignant neoplasm of ovary

3.5

7.8

C34.36

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma

6.1

7.8

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

6.1

7.8

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

3.9

7.8

M54.5

ICD-10 Finland

Low back pain

1.2

7.8

2076

18464

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

3.8

7.8

XX9XW

NOMESCO Finland

2.5

7.8

223

A12AA04

ATC

calcium carbonate; oral

2.0

7.8

472

K76.6

ICD-10 Finland

Portal hypertension

10.8

7.8

B82

ICPC

Anaemia other/unspecified

1.7

7.8

138

796

N05AL05

ATC

amisulpride; oral

9.4

7.8

J20.6

ICD-10 Finland

Acute bronchitis due to rhinovirus

9.4

7.8

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

3.4

7.7

103

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

2.1

7.7

413

N07BA03

ATC

varenicline; oral

1.5

7.7

271

1857

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.5

7.7

281

1939

C81.3

ICD-10 Finland

Lymphocyte depleted classical Hodgkin lymphoma

45.0

7.7

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

3.0

7.7

142

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

2.6

7.7

212

K72.9

ICD-10 Finland

Hepatic failure, unspecified

3.2

7.7

120

7806A

ICD-9 Finland

General symptoms, Pyrexia of unknown origin

2.5

7.7

219

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

2.6

7.7

204

QBA00

NOMESCO Finland

Puncture of skin of trunk

3.4

7.7

104

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.3

7.6

570

4442

L95.8

ICD-10 Finland

Other vasculitis limited to skin

3.9

7.6

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.5

7.6

214

1395

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

2.3

7.6

277

C92.7

ICD-10 Finland

Other myeloid leukaemia

18.3

7.6

L01XX17

ATC

[U] topotecan; systemic

18.3

7.6

L01EA03

ATC

nilotinib; oral

18.3

7.6

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

18.3

7.6

S94

ICPC

Ingrowing nail

2.0

7.6

446

D46

ICD-10 Finland

Myelodysplastic syndromes

25.0

7.6

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

3.1

7.6

127

R03DC03

ATC

montelukast; oral

1.2

7.6

946

7852

T81.9

ICD-10 Finland

Unspecified complication of procedure

1.9

7.6

105

557

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.3

7.5

530

4096

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

7.5

236

1582

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.4

7.5

351

2546

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.3

7.5

284

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

3.4

7.5

101

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

2.8

7.5

162

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.5

7.5

272

1879

-69

ICPC

Other reason for encounter NEC

1.5

7.4

226

1502

PG1UT

NOMESCO Finland

Percutaneous aspiration throbectomy

4.0

7.4

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

1.6

7.4

161

986

2959C

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]

3.6

7.4

C94.7

ICD-10 Finland

Other specified leukaemias

80.1

7.4

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016228) CD19 cells/100 cells in Blood

323

270

12.35

323.31

2.5

1.9

7.6

7.9

0.08

316

260

(21494814) CD8 cells/100 lymphocytes in Specimen

317

260

12.58

320.92

2.5

1.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2018

8500

2.75

314.77

2.4

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2017

8508

2.74

313.62

2.5

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1493

5360

3.12

312.01

1.5

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

413

510

8.42

311.78

3.4

2.5

835.3

692.3

e6/l

0.19

154

211

(3017143) Hepatitis C virus Ab [Presence] in Serum

1981

8328

2.75

309.68

1.7

1.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

282

202

14.36

309.31

2.4

1.9

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

411

511

8.36

308.51

3.3

2.5

644.0

503.5

e6/l

0.81

333

428

(21494434) Karyotype in Bone marrow

891

518

18.89

307.65

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2081

5785

4.33

307.65

4.2

2.7

9.8

10.6

g/l

9.78

1934

5296

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6173

39219

2.66

307.65

12.3

6.6

1.2

mmol/l

0.36

4969

33154

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

905

718

13.84

307.65

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

949

2202

4.68

307.65

3.7

2.8

3.4

3.6

g/l

4.70

913

2092

(3002030) Lymphocytes/100 leukocytes in Blood

6960

37743

4.22

307.65

13.7

6.0

29.8

27.9

21.38

6687

35048

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

930

1752

5.78

307.65

2.4

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3714

8554

6.51

307.65

8.2

3.9

258.2

240.9

u/l

6.57

3576

8048

(3000093) Morphology [Interpretation] in Blood Narrative

497

696

7.48

307.65

1.2

1.1

—

(3011412) CD3 cells [#/volume] in Blood

659

691

10.18

307.65

3.1

2.4

1.1

e9/l

0.00

450

407

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

776

1250

6.67

307.65

2.5

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1554

5263

3.34

307.65

2.9

2.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

641

974

6.99

307.65

2.0

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

674

1332

5.37

307.65

1.5

1.4

104.9

116.9

u/ml

1.45

141

282

(3023520) Reticulocytes [#/volume] in Blood

2524

6364

5.05

307.65

4.7

2.4

72.4

69.3

e9/l

2.89

1964

4780

(3008757) Leukocyte morphology finding [Identifier] in Blood

523

804

6.83

307.65

6.9

3.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

886

1692

5.68

307.65

1.9

1.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2918

12708

2.88

307.65

7.2

3.3

0.8

mmol/l

10.98

2804

11848

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2770

12444

2.74

307.65

2.7

1.8

—

(3023368) Bacteria identified in Blood by Culture

4479

20907

3.17

307.65

7.8

4.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1004

1451

7.62

307.65

7.7

5.3

2025.2

1491.0

iu/ml

0.12

142

209

(4035726)

1925

6930

3.23

307.65

1.6

1.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

550

547

10.62

307.65

2.6

2.1

72.4

72.1

0.12

529

519

(3018010) Neutrophils/100 leukocytes in Blood

6781

37225

3.92

307.65

12.7

5.8

54.1

57.3

52.35

6502

34702

(40760892) CBC W Ordered Manual Differential panel - Blood

3527

16913

2.73

307.65

9.6

4.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1693

4485

4.38

307.65

2.4

1.8

1.3

1.4

g/l

0.52

1555

4097

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

551

801

7.24

307.65

2.1

1.5

—

(3019069) Monocytes/100 leukocytes in Blood

6919

36784

4.31

307.65

14.1

6.2

9.2

8.6

20.15

6664

34347

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1486

1073

16.25

307.65

1.9

1.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2697

11294

2.94

307.65

2.9

2.5

2.3

g/l

3.81

2541

10451

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2348

10171

2.74

307.65

9.0

5.8

1.0

mmol/l

0.44

2246

9458

(3002179) Metamyelocytes/100 leukocytes in Blood

2137

5874

4.41

307.65

7.2

3.7

0.8

0.6

3.37

1014

1248

(3004809) Band form neutrophils/100 leukocytes in Blood

874

1196

7.95

307.65

5.4

3.1

1.5

1.4

0.28

736

915

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

542

535

10.69

307.65

2.6

2.1

11.4

14.8

3.90

220

261

(3024561) Albumin [Mass/volume] in Serum or Plasma

5414

33930

2.40

307.65

8.3

4.8

34.1

35.5

g/l

53.03

5117

31457

(3001604) Monocytes [#/volume] in Blood

6915

39115

3.88

307.65

12.4

5.7

0.6

e9/l

2.26

6333

33516

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1183

3459

3.77

307.65

2.2

1.6

1.4

1.6

g/l

8.01

1007

2950

(3010503) CD19 cells [#/volume] in Blood

434

416

10.89

307.65

3.2

2.4

0.5

0.2

e9/l

0.73

422

400

(3006315) Basophils [#/volume] in Blood

6951

39288

3.92

307.65

12.4

5.7

0.0

e9/l

1.63

6365

33665

(3019198) Lymphocytes [#/volume] in Blood

6996

40216

3.86

307.65

12.6

5.8

2.5

1.9

e9/l

8.61

6500

35157

(3006504) Eosinophils/100 leukocytes in Blood

6875

36586

4.24

307.65

13.4

5.9

2.8

2.9

2.35

6614

34001

(3025159) Blasts/100 leukocytes in Blood

2010

5792

4.14

307.65

7.6

4.0

0.3

0.4

0.26

1076

1342

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1562

5540

3.18

307.65

2.3

1.6

—

(42870588) Differential panel, method unspecified - Blood

5812

26729

4.06

307.65

12.8

5.8

—

(21494815) CD4 cells/100 lymphocytes in Specimen

590

574

10.90

307.65

2.7

2.3

34.5

43.3

2.65

(3018418) pH of Serum or Plasma

4318

23121

2.60

307.65

7.9

3.9

7.4

0.40

1224

4361

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6816

40617

3.44

307.65

13.8

6.0

11.2

11.5

umol/l

1.08

6629

38484

(3022948) Iron [Moles/volume] in Serum or Plasma

2787

12216

2.82

307.65

3.0

2.5

13.4

13.0

umol/l

1.92

2634

11311

(3021589) Normoblasts [#/volume] in Blood

5557

34558

2.48

307.65

21.3

9.4

0.0

e9/l

4.53

4826

28016

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

534

502

11.22

307.65

2.6

2.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2612

10511

3.05

307.65

3.0

2.6

24.4

22.4

7.83

2328

8942

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

908

1702

5.80

307.65

2.6

1.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

7586

45306

4.44

307.65

24.8

8.7

3.8

4.1

e9/l

11.25

7117

39325

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

727

1479

5.24

307.65

1.5

1.4

21.5

18.6

u/ml

—

(3017181) Myelocytes/100 leukocytes in Blood

2400

6438

4.66

307.65

7.4

3.9

1.2

0.9

4.82

1349

1720

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1074

1068

11.22

307.65

1.4

1.2

43.7

34.0

u/l

0.89

947

931

(3021440) Promyelocytes/100 leukocytes in Blood

2205

6143

4.38

307.65

7.4

3.9

0.2

0.1

1.02

1258

1602

(3045142) Bone marrow Pathology biopsy report

1251

653

21.93

307.65

1.5

1.3

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5730

35578

2.56

307.65

10.8

6.0

1.2

mmol/l

0.11

5383

32217

(3013115) Eosinophils [#/volume] in Blood

7054

40549

3.93

307.65

13.7

5.9

0.2

e9/l

0.13

6504

35355

(3020630) Protein [Mass/volume] in Serum or Plasma

1777

6396

3.19

307.65

3.2

2.5

65.6

66.4

g/l

3.58

1657

5809

(3022096) Basophils/100 leukocytes in Blood

6770

35490

4.21

307.65

13.3

5.9

0.7

6.55

6520

33009

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

8008

60396

3.16

307.65

17.8

7.4

84.3

78.6

u/l

18.26

7796

56835

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

733

1481

5.28

307.65

1.5

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

3106

8533

4.94

307.65

4.5

2.4

1.8

0.45

2849

7513

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

815

1112

7.93

307.65

3.9

2.8

20320.5

1936.4

u/ml

1.07

(3026493) Urate [Moles/volume] in Serum or Plasma

3667

20536

2.29

306.01

4.9

2.6

1958.2

4412.3

umol/l

5.85

3344

17704

(40758558) Short blood count panel - Blood

3575

19982

2.27

297.92

18.3

6.6

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

388

493

8.16

285.89

3.5

2.6

0.2

e9/l

1.74

329

426

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

671

1468

4.84

285.87

1.3

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

399

525

7.89

285.43

1.5

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

617

1301

5.00

274.47

1.8

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

540

1015

5.58

273.54

1.8

1.4

—

(3026782) Osmolality of Urine

2899

15358

2.28

269.61

3.5

2.8

523.9

546.2

mosm/kgh2o

6.73

2589

13055

(46235355) HIV 1 and 2 tests - Meaningful Use set

2469

12323

2.36

263.22

1.8

—

(3002582) Erythrocytes [#/volume] in Urine

3930

23804

2.12

258.00

4.3

3.3

92.3

85.5

e6/l

0.10

3283

18220

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2178

10368

2.43

257.77

1.7

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

304

324

9.66

257.20

5.1

3.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

800

2182

3.91

254.91

1.4

1.2

—

(3032080) INR in Blood by Coagulation assay

4827

31706

2.07

253.11

11.3

9.0

1.2

1.3

inr

2.10

1798

8956

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

614

1386

4.67

251.24

1.4

1.3

265.7

273.2

u/ml

0.25

409

839

(3000850) Epithelial cells [#/volume] in Urine

2999

16586

2.18

246.94

3.4

2.6

5.9

5.4

e6/l

0.82

2713

14509

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

816

2360

3.69

238.41

3.5

3.1

3.3

2.2

ratio

0.37

189

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

951

3053

3.35

236.38

2.6

1.9

1.7

2.3

ug/l

0.88

883

2691

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

293

333

9.05

235.98

2.1

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

826

2425

3.64

235.93

3.6

3.2

37.6

48.7

mg/l

1.03

655

1973

(3034860) Kappa light chains.free [Mass/volume] in Serum

826

2425

3.64

235.93

3.6

3.2

56.5

78.7

mg/l

0.43

653

1970

(3013826) Glucose [Moles/volume] in Serum or Plasma

6275

46019

2.09

235.74

8.1

4.6

6.7

mmol/l

0.12

6040

42997

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

292

333

9.02

234.54

2.1

1.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2370

12143

2.27

233.70

3.5

2.1

30.3

29.9

2.81

2312

11785

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

366

555

6.82

230.13

1.8

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

808

2381

3.62

229.32

4.0

2.5

89.8

91.3

0.97

752

2240

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1517

6415

2.63

228.51

7.3

3.7

1.2

mmol/l

2.52

1401

5605

(3030467) Casts [#/volume] in Urine by Automated count

3598

21866

2.04

226.51

4.2

3.2

0.4

e6/l

0.08

2973

16417

(36304419) Bacteria [Presence] in Urine

3520

21260

2.05

225.10

4.0

3.1

—

(3042936) Bacteria identified in Isolate by Culture

2180

10984

2.28

222.36

2.3

2.0

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1892

9008

2.38

220.03

5.2

2.7

9.4

8.3

umol/l

1.01

1684

7815

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3306

19649

2.05

219.85

2.7

2.3

3.4

2.9

mg/l

14.24

2884

16783

(3018095) Leukocytes [#/volume] in Urine

4254

27759

1.97

215.71

5.0

3.7

105.9

98.1

e6/l

0.19

3403

19631

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

356

561

6.56

215.67

2.0

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

514

1139

4.71

214.69

1.8

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

477

995

5.00

214.21

1.8

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4826

33002

1.95

211.71

4.1

2.8

261.6

129.0

ug/l

21.88

4510

30481

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

363

595

6.30

211.55

1.7

1.8

4.0

4.1

mg/l

0.14

339

571

(3015377) Calcium [Moles/volume] in Serum or Plasma

4082

26455

1.96

209.32

6.0

3.3

2.3

2.4

mmol/l

11.54

3724

22961

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

419

799

5.44

208.34

2.7

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2663

14940

2.09

204.38

2.1

1.5

2.2

2.4

g/l

6.17

1941

8901

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

798

2518

3.37

202.97

3.4

2.3

1.3

0.9

g/l

1.65

705

2158

(3033658) Prothrombin time (PT) actual/Normal

3290

20138

1.97

196.36

7.3

4.0

87.5

89.9

6.32

3198

19655

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

389

732

5.50

196.18

2.8

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

652

1845

3.72

195.85

3.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

877

2993

3.13

195.70

3.1

2.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

876

2989

3.13

195.54

3.1

2.2

3.7

3.8

g/l

0.94

664

2115

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

877

2995

3.13

195.47

3.1

2.2

7.1

7.4

g/l

5.25

677

2219

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3900

25343

1.92

194.23

5.6

3.2

36.8

34.9

u/l

0.74

3745

23977

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

837

2794

3.19

193.86

3.2

2.2

3.2

3.1

g/l

2.05

665

2163

(3017354) Segmented neutrophils/100 leukocytes in Blood

397

770

5.34

193.60

6.0

3.1

51.3

58.9

5.92

256

499

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

725

2221

3.45

193.00

3.2

2.2

0.1

0.0

g/l

0.27

670

2024

(3037756) Immunofixation for Serum or Plasma

593

1588

3.92

192.81

1.7

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

137

23.55

190.74

1.1

—

(40768795) Lymph node Pathology biopsy report

385

739

5.39

189.91

1.4

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

283

401

7.24

189.25

3.3

2.5

38.8

38.3

0.10

143

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

591

1613

3.84

186.94

1.7

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

369

697

5.47

185.25

1.3

1.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

238

284

8.57

184.27

2.6

2.3

31.6

27.9

2.20

224

266

(44790048)

404

831

5.03

184.16

2.1

1.5

—

(44806118)

404

831

5.03

184.16

2.1

1.5

—

(44790047)

404

831

5.03

184.16

2.1

1.5

—

(44790049)

404

831

5.03

184.16

2.1

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

377

732

5.32

183.56

2.5

2.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1533

7167

2.36

182.83

2.6

2.2

363.2

373.9

nmol/l

1.11

1454

6582

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

815

2781

3.11

181.49

3.1

2.2

10.5

10.2

g/l

0.52

700

2332

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

293

457

6.58

179.11

1.9

1.4

—

(3006245) CD3-CD19+ cells/100 cells in Blood

237

292

8.30

178.76

2.8

2.5

12.9

11.2

0.64

216

270

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

672

2059

3.44

178.53

3.2

2.2

0.0

g/l

0.36

617

1868

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

127

23.82

177.65

2.3

4.3

1.4

1.6

mg/l

0.13

(40765096) Chromosome analysis panel by Banding

200

10.19

177.04

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1634

7983

2.27

175.10

5.3

3.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

675

2100

3.38

174.97

6.4

4.2

1.5

mg/l

0.26

629

1934

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

159

113

14.29

174.86

1.3

—

(40761536) Microorganisms panel - Urine sediment

1413

6508

2.38

173.70

5.0

4.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

658

2024

3.42

173.64

3.2

2.2

0.0

g/l

0.00

617

1861

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

269

398

6.93

172.84

2.0

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

711

2303

3.26

172.60

3.1

2.1

37.6

37.7

g/l

0.08

637

1971

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

269

403

6.84

170.83

2.0

1.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1544

7453

2.28

169.87

2.7

2.3

0.2

g/l

4.31

1428

6942

(3048879) Bone marrow aspiration report

193

195

10.08

169.57

2.4

1.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1473

7000

2.31

168.04

11.2

7.4

9.8

mmol/l

0.03

1411

6686

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

684

2212

3.26

166.34

1.7

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3711

24655

1.83

164.79

3.4

2.6

53.6

58.1

u/l

8.46

3482

22717

(3000060) B lymphocytes [#/volume] in Blood

195

209

9.51

164.05

2.8

2.6

1427.4

213.8

e6/l

1.09

117

120

(3044640) Blood type and Crossmatch panel - Blood

3729

24936

1.82

161.10

4.9

2.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

669

2178

3.23

160.79

3.8

2.7

197.3

193.0

0.56

642

2074

(3031040) Bacteria [#/volume] in Urine by Automated count

6516

51461

1.86

160.64

5.8

4.5

736.1

1629.7

e6/l

1.27

149

706

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

748

2610

3.03

159.65

2.6

2.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

356

746

4.92

158.61

1.4

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

1936

10545

2.05

154.99

1.5

1.3

607.1

527.9

titre

0.90

429

2206

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

101

27.58

149.00

5.4

4.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4958

36658

1.74

146.82

7.3

4.0

—

(3012501) Base excess in Blood by calculation

561

1745

3.35

144.95

5.2

4.1

2.5

mmol/l

0.09

405

1181

(3009445) Proteinase 3 Ab [Units/volume] in Serum

857

3383

2.69

144.85

1.5

1.6

10.6

17.1

u/ml

0.78

(3013290) Carbon dioxide [Partial pressure] in Blood

561

1746

3.35

144.82

5.2

4.1

5.0

kpa

0.07

548

1713

(3027315) Oxygen [Partial pressure] in Blood

563

1758

3.34

144.56

5.2

4.2

8.5

8.6

kpa

0.84

550

1724

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2731

17059

1.85

143.81

2.5

1.8

1.6

1.2

mg/l

4.73

2160

13012

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

658

2275

3.03

142.33

1.8

1.7

—

(3013707) Erythrocyte sedimentation rate by Westergren method

7068

58142

1.86

142.22

6.3

4.1

15.4

12.2

mm/h

38.03

6657

53775

(3037467) Urinalysis macro (dipstick) panel - Urine

6654

53796

1.80

141.10

5.7

4.3

—

(3036489) Thrombin time

765

2894

2.79

140.31

3.5

2.2

22.0

21.5

1.49

700

2524

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1574

8270

2.08

137.27

4.8

4.1

25.7

28.3

ug/l

0.13

1290

6705

(3000012) Reticulocyte production index

236

387

6.23

137.23

1.9

1.3

—

(3010421) pH of Blood

604

2036

3.10

136.42

5.2

4.1

7.4

1.41

548

1715

(1616796) Gas panel - Central venous blood

543

1730

3.27

134.80

4.5

3.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

303

637

4.88

134.37

3.0

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

303

637

4.88

134.37

3.0

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

303

637

4.88

134.37

3.0

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

143

132

10.98

133.75

3.3

1.8

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1070

4932

2.32

128.98

10.2

7.6

24.9

24.8

mmol/l

0.34

1056

4900

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

592

2054

3.01

126.98

2.0

12.2

11.1

mg/l

0.95

544

1900

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

696

2655

2.75

125.25

1.8

1.6

354.7

259.7

titre

0.27

110

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

111

14.77

124.53

1.3

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

1653

9227

1.96

120.19

2.0

1.8

—

(3026008) Bacteria identified in Urine by Culture

3397

23537

1.69

119.84

3.5

3.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

178

252

7.18

119.00

1.5

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

625

2321

2.81

118.24

2.2

1.6

0.2

g/l

5.75

580

2198

(3019309) Folate [Moles/volume] in Red Blood Cells

2324

14532

1.80

117.93

2.0

1.7

1211.3

1167.0

nmol/l

1.42

1833

10933

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

39.73

116.54

10.0

7.4

—

(4212803)

101

15.46

116.17

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

18.05

115.62

1.5

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

631

2394

2.75

114.52

2.1

1.6

1.1

1.2

g/l

4.98

594

2264

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

676

2667

2.65

113.58

4.7

3.2

0.3

u/ml

0.55

430

1517

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

163

221

7.49

113.25

4.4

2.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

954

4450

2.27

111.03

1.8

1.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

171

251

6.92

110.60

1.8

2.0

459.1

24618.1

u/ml

0.88

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

487

1635

3.09

110.40

1.6

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

487

1635

3.09

110.40

1.6

1.3

—

(40758292) HTLV I+II Ab panel - Serum

116

105

11.17

109.90

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2707

18036

1.70

108.08

1.8

1.5

20.1

20.4

nmol/l

0.54

2438

15381

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

156

214

7.40

107.27

1.3

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

490

1683

3.02

106.70

3.1

2.5

15.9

16.4

1.11

255

881

(3024980) IgG subclass 4 [Mass/volume] in Serum

411

1276

3.32

106.11

1.6

0.8

g/l

0.54

293

968

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3194

22317

1.65

105.82

3.7

3.0

1709.4

1387.2

ng/l

2.52

2789

19190

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

149

197

7.67

105.82

2.4

1.8

60.8

35.0

u/l

0.72

143

178

(3024471) HLA-A [Type]

160

230

7.06

105.49

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

230

471

4.98

105.13

1.3

1.2

—

(3042631) Mycobacterium sp identified in Specimen

358

1037

3.55

103.02

2.5

2.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

175

292

6.09

99.97

4.0

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

174

290

6.09

99.51

4.0

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

174

290

6.09

99.51

4.0

1.8

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

348

1015

3.52

99.07

7.5

6.3

11.7

11.6

mg/l

0.06

326

931

(3000494) Fungus identified in Specimen by Culture

1575

9179

1.86

98.51

1.9

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

405

1309

3.19

97.81

5.6

3.6

57.8

30.3

u/ml

1.54

399

1267

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

556

2144

2.69

97.46

1.5

1.4

12.6

13.6

iu/ml

0.06

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

198

382

5.27

96.90

3.7

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

198

382

5.27

96.90

3.7

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

198

382

5.27

96.90

3.7

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

198

382

5.27

96.90

3.7

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1318

7285

1.94

96.87

7.0

4.0

5.8

kpa

1.91

1273

7075

(3002032) Base excess in Venous blood by calculation

1314

7258

1.94

96.76

7.0

4.0

1.9

mmol/l

0.09

1067

5906

(3000991) Gas panel - Venous blood

1232

6683

1.97

95.60

11.0

8.3

—

(3024932) HLA-DR beta [Type]

151

227

6.74

95.51

1.3

1.1

—

(3012544) pH of Venous blood

1348

7552

1.92

95.01

7.0

4.0

7.4

0.46

(3016650) Hepatitis A virus Ab [Presence] in Serum

385

1229

3.22

94.90

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4254

32463

1.57

94.23

2.8

2.3

77.0

77.5

nmol/l

0.67

3921

29169

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3946

29609

1.57

94.10

4.6

3.6

59.8

69.4

ng/l

0.15

3012

20266

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2751

19042

1.63

91.72

4.6

2.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

729

3289

2.32

91.15

1.9

41.5

39.0

u/l

1.97

643

2892

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

968

4915

2.08

90.03

5.8

3.9

2.1

1.8

mmol/l

2.58

713

3661

(3035350) Ketones [Presence] in Urine by Test strip

4820

38090

1.54

89.48

4.6

3.7

0.0

estimate

1.08

1475

6888

(3041096) Erythrocytes [Presence] in Urine by Automated

2889

20356

1.60

88.94

4.5

3.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

4830

38234

1.54

88.62

6.0

4.9

0.0

estimate

0.80

1494

7012

(3009343) pH of Capillary blood

988

5092

2.05

88.16

5.8

4.0

7.4

0.79

200

617

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8571

78167

2.06

88.02

33.7

14.1

24.5

23.9

mg/l

0.99

7673

62013

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

178

341

5.30

87.80

1.3

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

379

1259

3.09

87.30

1.1

—

(4062490)

290

816

3.63

87.12

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

4862

38663

1.53

86.47

4.7

3.7

0.0

estimate

0.26

1446

6838

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

991

5155

2.03

86.10

5.9

4.0

5.1

5.2

kpa

0.93

924

4776

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4175

32156

1.54

85.93

2.2

2.0

92.0

95.9

pmol/l

6.13

2479

16572

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1947

12519

1.70

85.52

3.8

3.0

2.7

2.5

e6/l

0.28

1158

6781

(3024139) IgG subclass 3 [Mass/volume] in Serum

285

815

3.57

83.56

1.4

0.4

g/l

0.03

191

572

(3027135) IgG subclass 1 [Mass/volume] in Serum

285

815

3.57

83.56

1.4

7.3

6.7

g/l

0.88

190

575

(3028192) IgG subclass 2 [Mass/volume] in Serum

285

816

3.57

83.41

1.4

2.6

2.9

g/l

2.27

190

574

(3014111) Lactate [Moles/volume] in Serum or Plasma

1219

6882

1.89

83.12

9.2

6.9

1.4

1.3

mmol/l

1.69

1182

6621

(3029937) Albumin [Presence] in Urine by Test strip

2881

20560

1.58

82.71

5.0

4.1

0.0

estimate

2.60

1396

6763

(3025941) Bacteria identified in Stool by Culture

851

4246

2.10

82.63

1.4

1.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

372

1262

3.03

82.59

2.3

1.9

1.7

mmol/l

0.11

359

1237

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2158

14393

1.65

81.87

4.4

3.0

2.5

mmol/l

1.64

1922

12538

(3032352) Blasts [#/volume] in Cerebral spinal fluid

11.98

81.42

4.2

3.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

495

1970

2.60

81.21

3.6

3.1

24.7

24.9

mmol/l

0.34

452

1720

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

16.86

80.61

3.1

3.3

—

(3023419) Bacteria identified in Sputum by Culture

309

957

3.30

79.97

2.5

2.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

493

1974

2.58

79.86

6.3

4.1

8.2

8.4

kpa

0.98

466

1837

(3005322) IgE [Units/volume] in Serum or Plasma

914

4740

2.03

79.81

1.8

1.3

339.4

214.2

u/ml

1.84

829

4381

(3022806) Fractional oxyhemoglobin in Capillary blood

318

1007

3.23

79.36

2.4

1.8

88.4

89.9

2.66

310

992

(40768804) Tissue Pathology biopsy report

4129

32091

1.51

79.20

2.4

2.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

785

3859

2.13

79.12

8.1

4.4

24.1

mmol/l

0.02

726

3472

(3014576) Chloride [Moles/volume] in Serum or Plasma

1581

9802

1.74

78.56

10.5

6.9

104.1

104.5

mmol/l

2.15

1546

9599

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

114

8.68

77.37

1.6

—

(3021901) Oxygen saturation in Capillary blood

393

1425

2.83

77.32

3.1

2.9

—

(3010375) cycloSPORINE [Mass/volume] in Blood

171

355

4.89

76.93

33.5

25.9

128.3

113.5

ug/l

1.73

144

294

(3027801) Oxygen [Partial pressure] in Arterial blood

1455

8931

1.74

74.56

9.1

7.2

11.9

12.4

kpa

3.54

1404

8515

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1454

8935

1.74

74.18

9.2

7.2

5.1

kpa

0.47

1400

8527

(3013862) HLA-DP [Type]

25.63

73.20

1.0

—

(3003396) Base excess in Arterial blood by calculation

1445

8904

1.74

72.89

9.2

7.2

1.4

1.0

mmol/l

2.24

1159

6984

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

527

2274

2.40

72.60

1.4

1.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

401

1523

2.71

72.16

1.4

1.2

104.4

176.8

titre

—

(3052851) Hemolysis interference index of Serum or Plasma

544

2391

2.35

71.87

4.3

3.2

—

(3002385) Erythrocyte distribution width [Ratio]

7298

64521

1.58

71.50

40.5

17.2

14.5

13.7

201.60

7224

63157

(40763590) HLA-DQ beta [Type]

25.13

71.24

1.0

—

(46236302) HLA-C [Type] by High resolution typing

25.13

71.24

1.0

—

(40760410) HLA-B [Type] by High resolution

25.13

71.24

1.0

—

(40760409) HLA-A [Type] by High resolution

25.13

71.24

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

107

8.58

71.23

1.8

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

866

4607

1.97

69.96

2.1

1.6

—

(3017732) Neutrophils [#/volume] in Blood

970

5378

1.90

69.23

4.3

2.9

4.0

4.1

e9/l

0.58

747

4147

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3172

23841

1.50

68.70

2.7

2.1

181.5

216.3

u/l

1.36

2982

22322

(3016502) Oxygen saturation in Arterial blood

1311

7988

1.74

68.48

9.7

7.6

95.0

95.7

2.90

1271

7694

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

12.49

68.31

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

343

1239

2.83

67.91

1.2

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

121

210

5.82

66.43

2.0

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

292

979

3.05

66.13

1.2

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

455

1916

2.44

66.09

1.3

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

9.25

65.64

2.0

1.9

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

18.67

65.63

1.3

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

152

327

4.71

65.55

36.2

34.4

7.5

7.3

ug/l

0.31

136

296

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

128

239

5.42

65.00

1.2

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1223

7423

1.74

64.49

3.2

2.4

33.1

44.8

u/l

1.11

1088

6329

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

20.52

64.45

2.2

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

404

1636

2.54

63.79

3.8

2.8

36.1

34.3

umol/l

0.66

340

1398

(3034770) Mitochondria Ab [Titer] in Serum

486

2162

2.32

62.32

1.2

710.0

901.4

titre

0.35

(3028433) Virus identified in Specimen by Culture

130

257

5.11

61.94

1.3

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

122

228

5.41

61.90

1.2

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1956

13538

1.56

60.94

3.6

2.8

1.1

1.4

e6/l

0.77

1181

7749

(3024891) Influenza virus A+B Ag [Presence] in Specimen

450

1980

2.34

59.16

1.4

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

480

2175

2.27

58.90

1.3

1.2

165.3

156.9

titre

0.06

193

(3019060) Gas panel - Arterial blood

894

5090

1.84

58.22

6.1

4.9

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

20.09

57.32

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

126

260

4.90

57.15

1.2

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2126

15167

1.52

57.13

4.2

3.7

504.7

486.4

ng/l

0.04

1701

11800

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

29.34

56.97

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

1010

6011

1.76

56.61

6.6

3.5

4.8

4.6

kpa

1.17

969

5818

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3690

29325

1.42

56.56

4.9

3.9

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1177

7367

1.68

54.84

10.4

7.9

116.9

121.4

g/l

8.97

1141

7103

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

208

642

3.29

54.15

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

247

846

2.97

53.88

1.2

88.0

63.1

u/l

1.05

181

562

(3019550) Sodium [Moles/volume] in Serum or Plasma

8590

80358

1.77

53.65

33.3

16.3

139.2

139.7

mmol/l

50.07

8458

78417

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

498

2385

2.15

53.23

1.6

0.3

4.5

iu/ml

0.96

107

518

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

494

2359

2.15

53.20

2.3

1.8

—

(40768797) Stomach Pathology biopsy report

1612

10979

1.56

53.04

1.3

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

317

1249

2.59

52.94

1.4

—

(3044889) 12 lead EKG panel

6256

54834

1.42

52.78

4.8

3.8

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5901

51202

1.41

52.74

4.5

3.1

65.6

48.1

u/l

20.08

5549

47602

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

110

220

5.05

51.76

1.2

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

8596

80583

1.75

51.21

34.2

16.4

4.0

mmol/l

1.20

8452

78478

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

612

3252

1.94

49.09

3.3

1.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

502

2495

2.07

48.62

2.0

1.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

582

3053

1.97

48.47

1.3

1.2

0.4

1.0

u/ml

2.19

291

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

281

1093

2.62

48.18

3.5

2.6

144.1

1421.5

u/ml

0.81

270

1049

(3051651) Icteric interference index of Serum or Plasma

165

476

3.51

47.80

4.9

3.4

—

(40768806) Pleura Pathology biopsy report

232

823

2.86

47.52

1.5

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

395

1812

2.23

46.97

2.6

2.2

126.9

129.9

g/l

1.11

314

1297

(3002256) Pathology report gross observation

1499

10304

1.54

46.73

1.4

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

290

1163

2.54

46.70

1.3

1.2

4.0

3.7

u/ml

0.05

112

382

(21494890) Protein electrophoresis panel - 24 hour Urine

225

804

2.84

45.48

2.1

2.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

147

5.69

44.68

1.4

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

139

375

3.75

44.51

2.2

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

139

375

3.75

44.51

2.2

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

701

4013

1.81

44.43

6.3

3.6

52.1

55.7

u/ml

0.22

677

3864

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

540

2846

1.95

44.30

3.7

3.5

1547.4

2210.0

u/ml

0.17

473

2428

(3009214) Lutropin [Units/volume] in Serum or Plasma

414

1992

2.13

43.65

1.6

1.4

10.9

10.6

u/l

0.15

335

1593

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

378

1758

2.20

43.45

2.2

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

278

1135

2.49

43.12

1.3

1.2

4.3

u/ml

0.00

131

495

(3012441) Differential panel - Pleural fluid

220

803

2.78

42.75

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

246

952

2.63

42.63

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

2711

21184

1.39

42.61

1.6

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

511

2692

1.95

41.95

2.8

2.3

515.3

563.8

ug/l

0.10

481

2530

(3019420) Tryptase [Mass/volume] in Serum or Plasma

139

391

3.59

41.88

1.9

1.5

11.0

8.1

ug/l

0.87

124

351

(3003434) Protein [Mass/volume] in Pleural fluid

260

1045

2.53

41.69

1.5

34.0

32.4

g/l

1.28

236

937

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

184

621

3.00

41.26

1.2

201.9

200.8

titre

0.01

114

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

184

621

3.00

41.26

1.2

234.3

217.7

titre

—

(3022145) Colonoscopy Study observation

1292

8818

1.54

41.16

1.4

1.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

705

4136

1.76

41.03

11.0

9.2

24.4

24.3

mmol/l

0.41

675

3860

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

160

504

3.21

40.37

2.1

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2200

16731

1.41

40.08

1.7

32380912.6

33439305.6

pmol/l

0.03

1819

13897

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

358

1684

2.17

39.99

2.3

1.5

41.5

23.0

e6/l

0.25

302

1291

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

358

1684

2.17

39.99

2.4

1.5

396.0

1214.2

e6/l

2.45

319

1363

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

333

1523

2.23

39.88

1.7

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

161

518

3.14

39.22

2.1

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

392

1926

2.08

39.10

2.1

1.4

606.3

516.7

mg/l

0.67

375

1832

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

157

499

3.18

39.04

1.2

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

337

1567

2.19

38.75

2.4

1.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7881

73295

1.46

38.48

29.3

13.2

80.6

80.7

ml/min/173m2

0.12

7048

60539

(3014148) Varicella zoster virus Ab [Titer] in Serum

225

877

2.60

38.46

1.2

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

539

2981

1.86

38.10

2.3

1.8

—

(40768793) Breast Pathology biopsy report

361

1741

2.12

37.83

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

245

1003

2.48

37.81

2.5

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

202

756

2.71

37.44

3.6

2.9

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

142

437

3.28

37.24

3.0

2.5

93.5

96.8

0.43

137

407

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

251

1047

2.44

37.20

1.1

1.6

1.5

g/l

2.70

229

939

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

931

6027

1.60

37.14

4.9

3.8

96.7

90.2

ng/l

1.14

817

5180

(3025468) Yersinia sp identified in Specimen by Organism specific culture

243

1000

2.47

37.09

2.6

1.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

794

4949

1.66

36.88

11.5

9.0

93.4

94.0

1.93

787

4930

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

243

1003

2.46

36.85

2.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

247

1028

2.44

36.79

2.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

243

1006

2.45

36.61

2.6

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

244

1014

2.44

36.46

2.6

1.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

155

5.00

36.05

1.2

—

(3047189) Immunofixation for 24 hour Urine

126

368

3.46

35.91

1.7

1.6

—

(40768441) Liver Pathology biopsy report

167

581

2.91

35.53

1.6

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

190

711

2.71

35.25

1.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

130

394

3.33

34.97

1.2

1.1

39.9

25.4

u/l

1.29

294

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

345

1687

2.08

34.86

2.1

1.4

3.8

mmol/l

0.21

327

1584

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

130

396

3.31

34.69

1.2

1.1

104.7

87.9

u/l

1.02

106

308

(3008152) Bicarbonate [Moles/volume] in Arterial blood

770

4843

1.64

34.44

9.2

7.1

24.7

24.6

mmol/l

0.29

734

4512

(40757373) Influenza virus identified in Isolate

139

5.14

34.32

1.7

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

696

4269

1.68

34.31

12.4

9.8

—

(3003181) Sodium [Moles/volume] in Urine

298

1387

2.19

34.20

1.6

1.4

64.2

63.8

mmol/l

0.06

234

1118

(3022313) Gas panel - Capillary blood

630

3765

1.72

34.20

7.0

4.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

988

6616

1.55

33.90

3.3

2.9

231.6

193.2

ng/l

1.83

899

6022

(3022493) Free Hemoglobin [Mass/volume] in Plasma

111

310

3.61

33.88

4.3

4.6

2002.7

66.3

mg/l

0.49

220

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

777

4923

1.63

33.73

11.6

9.0

0.7

1.06

769

4888

(3035637) Corticotropin [Mass/volume] in Plasma

241

1032

2.37

33.72

1.7

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

205

821

2.53

33.18

4.7

3.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

250

1097

2.31

33.08

1.1

113.6

117.2

0.85

224

989

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

322

1565

2.09

33.07

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6588

59962

1.33

32.96

4.6

4.0

14.9

14.8

pmol/l

1.15

6040

54481

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

111

316

3.54

32.93

2.5

2.1

38.2

203.6

ug/l

0.82

105

290

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

775

4940

1.62

32.80

11.5

8.9

1.4

0.78

768

4907

(3008295) Osmolality of Serum or Plasma

199

793

2.54

32.55

1.6

1.4

277.5

279.7

mosm/kgh2o

0.69

169

608

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

135

439

3.11

32.37

13.1

18.1

1364.7

1426.2

nmol/l

0.31

126

424

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

184

710

2.62

32.16

1.3

735.7

342.6

u/l

0.82

175

670

(3013512) EKG study

2802

22802

1.33

31.75

4.5

3.9

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

747

4786

1.61

30.91

3.3

4.5

pmol/l

0.03

630

4246

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

268

1247

2.18

30.81

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

111

332

3.37

30.54

1.3

1.8

151.1

149.5

0.06

105

311

(4306422)

250

1136

2.23

30.47

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

160

594

2.72

30.20

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

5.76

30.13

1.2

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

197

4.14

30.07

1.3

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

215

923

2.36

29.95

1.5

6170.6

2227.3

e6/l

0.50

172

658

(3023420) DNA double strand Ab [Units/volume] in Serum

197

814

2.45

29.87

1.9

1.4

30.5

23.4

iu/ml

0.90

(3007919) Fasciola sp Ab [Titer] in Serum

22.05

29.55

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

144

512

2.84

29.51

1.6

6.6

5.5

u/l

0.28

243

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

293

1442

2.06

29.13

3.9

3.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

422

2352

1.83

29.05

1.4

271.4

273.1

ug/g

0.06

267

1376

(21491868) Cryoglobulin [Mass/volume] in Serum

270

3.58

29.05

1.3

1.2

0.3

0.2

g/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

7.72

28.87

1.7

1.5

1.1

1.7

mg/l

0.41

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

7.72

28.87

1.7

1.5

3.0

3.7

mg/l

0.22

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

7.72

28.87

1.7

1.5

1.7

0.9

mg/l

0.39

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

7.72

28.87

1.7

1.5

1.9

3.1

mg/l

0.66

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

7.72

28.87

1.7

1.5

1.2

0.7

mg/l

0.45

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

7.72

28.87

1.7

1.5

0.7

2.0

mg/l

1.27

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

7.72

28.87

1.7

1.5

3.0

1.5

mg/l

0.54

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

7.72

28.87

1.7

1.5

2.2

1.5

mg/l

0.21

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

7.72

28.87

1.7

1.5

1.3

1.8

mg/l

0.26

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

14.48

28.77

1.0

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

648

4086

1.63

28.57

3.8

2.7

0.2

0.3

e6/l

1.79

637

3978

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

171

4.29

28.48

1.5

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

370

1991

1.89

28.46

1.3

14.0

7.0

u/ml

0.83

307

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

247

1150

2.18

28.37

1.2

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

7.35

28.36

1.7

1.6

1.4

1.2

mg/l

0.09

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

150

557

2.72

28.33

1.3

15.1

12.4

u/l

0.41

141

511

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

366

1968

1.89

28.22

1.3

10.3

3.4

u/ml

0.65

193

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

126

429

2.96

27.95

10.0

12.6

758.5

825.2

nmol/l

0.84

120

407

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

122

409

3.01

27.81

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

178

726

2.48

27.78

3.5

3.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

218

973

2.27

27.77

1.5

1.4

0.2

0.4

nmol/l

2.65

145

745

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

390

2152

1.85

27.73

1.3

31.6

38.4

u/ml

0.23

131

(3042733) HLA Ab [Presence] in Serum

241

3.68

27.72

5.2

4.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

195

834

2.37

27.43

1.5

95412.4

56409.8

e6/l

0.46

127

484

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8664

83055

1.53

27.23

23.0

10.4

27.3

26.4

u/l

2.58

8502

80090

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

155

598

2.62

27.16

1.4

1.3

2.4

2.0

mmol/l

1.38

144

564

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

312

1626

1.95

26.43

1.3

1.2

8.7

3.8

u/ml

0.35

111

(4268621)

182

771

2.39

26.17

2.4

2.3

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

138

4.52

25.83

1.3

40.6

101.6

titre

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

113

379

3.01

25.77

1.8

1.3

61.1

63.9

0.11

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

139

523

2.68

25.63

2.4

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

314

1660

1.92

25.50

3.7

3.4

242.7

593.2

u/ml

1.11

286

1514

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

133

491

2.73

25.45

1.1

1.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

131

480

2.75

25.43

1.2

33.0

23.1

u/l

1.03

118

399

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

133

493

2.72

25.25

1.1

1.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

133

494

2.72

25.15

1.2

142.9

86.9

u/l

1.09

121

425

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.58

25.06

1.3

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

308

1629

1.92

24.99

1.2

2.2

19.8

u/ml

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

110

370

3.00

24.98

2.9

5.2

49.1

10149.9

u/ml

—

(3036782) Glucose [Moles/volume] in Pleural fluid

170

715

2.40

24.86

1.4

6.1

6.4

mmol/l

0.77

159

657

(3027273) Bicarbonate [Moles/volume] in Venous blood

579

3673

1.61

24.86

5.0

3.4

25.1

25.2

mmol/l

0.33

557

3557

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

186

814

2.31

24.86

1.2

1.1

90.3

96.2

1.98

171

765

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

553

3488

1.62

24.30

5.7

2.9

0.7

0.04

536

3332

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

531

3320

1.64

24.17

7.7

4.4

24.9

24.8

mmol/l

0.65

490

3068

(3018405) Lactate [Moles/volume] in Arterial blood

453

2718

1.70

24.16

4.9

4.0

1.5

1.4

mmol/l

0.75

445

2672

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

186

826

2.28

24.03

1.6

1.8

811.4

1653.3

titre

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

696

4655

1.53

23.73

6.2

3.4

122.0

129.2

g/l

10.66

676

4533

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2118

17158

1.30

23.42

1.3

1.2

1.8

u/ml

2.06

537

4512

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

110

384

2.89

23.40

3.9

4.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

137

537

2.57

23.31

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

185

3.80

23.27

1.4

1.1

—

(3037121) Protein [Mass/volume] in Urine

448

2711

1.68

23.15

3.9

3.2

0.4

0.3

g/l

0.37

275

1156

(3023323) Follitropin [Units/volume] in Serum or Plasma

506

3160

1.64

23.14

1.6

1.4

26.9

29.7

iu/l

1.13

429

2691

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

104

356

2.94

22.93

1.2

1.1

31.9

23.5

u/ml

0.12

(3020891) Body temperature

495

3091

1.63

22.64

5.9

4.8

—

(3004451) EKG impression Narrative

107

377

2.86

22.40

1.4

1.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

8.77

22.39

1.2

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

190

878

2.19

22.32

9.8

13.7

7.5

7.3

mmol/l

0.17

164

741

(3029634) Reagin Ab [Titer] in Serum by VDRL

208

997

2.11

22.26

1.9

2.0

17.0

2.8

titre

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

378

2207

1.74

22.26

1.3

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

191

3.68

22.24

1.5

1.4

13.0

13.5

g/l

0.16

153

(3014765) Yersinia sp identified in Stool by Organism specific culture

380

2227

1.74

22.08

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

381

2236

1.73

22.03

1.3

1.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

250

3.30

22.00

1.3

1.9

187.4

179.9

0.23

237

(3045788) Cell count panel - Pleural fluid

163

713

2.31

21.86

1.6

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

179

816

2.22

21.76

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

1251

9481

1.37

21.72

2.7

2.3

183.6

131.4

ug/g

1.66

1013

7442

(3009466) Valproate [Moles/volume] in Serum or Plasma

221

1094

2.04

21.71

6.4

5.0

393.4

365.1

umol/l

2.02

193

942

(3019832) Treponema pallidum Ab [Presence] in Serum

816

5744

1.46

21.62

1.6

1.7

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

139

570

2.46

21.55

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

139

570

2.46

21.55

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

139

571

2.46

21.47

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

101

4.77

21.45

2.2

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

119

454

2.64

21.42

1.2

1.1

ratio

0.97

151

(3017704) Immunofixation for Urine

111

409

2.73

21.39

1.9

1.6

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

139

573

2.45

21.31

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

139

573

2.45

21.31

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

139

574

2.44

21.23

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1348

10369

1.35

21.23

23.4

24.9

1.4

1.3

inr

1.32

204

1490

(40768446) Kidney Pathology biopsy report

303

3.02

21.10

1.6

—

(3016018) Differential panel - Cerebral spinal fluid

180

835

2.18

20.97

2.4

1.5

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

238

3.30

20.92

1.8

1.3

28.0

26.0

0.08

(3001893) Eosinophils/100 leukocytes in Pleural fluid

234

3.31

20.79

1.5

1.4

1.2

2.8

1.78

194

(21494755) Public health laboratory ask at order entry panel

434

6802

0.62

20.55

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

221

1120

2.00

20.37

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

526

3436

1.56

19.91

5.3

4.0

49.4

48.4

0.39

521

3392

(3052592) Norovirus Ag [Presence] in Stool

146

3.92

19.84

1.5

1.3

—

(3036603) Volume of Urine

129

532

2.44

19.79

1.5

1.6

2134.6

1913.5

0.38

126

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

120

480

2.52

19.65

1.4

1.2

—

(3035880) pH of Pleural fluid

112

434

2.60

19.58

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1670

13389

1.30

19.49

1.3

41.8

34.8

iu/ml

0.70

528

4135

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

181

867

2.11

19.46

1.2

1.1

—

2.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

101

373

2.73

19.42

1.1

4.6

3.6

iu/ml

—

(3020876) Protein [Mass/time] in 24 hour Urine

148

656

2.28

19.30

1.8

1.9

1.2

1.6

g/24h

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

120

485

2.49

19.24

1.4

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

116

462

2.53

19.18

1.2

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

236

3.20

19.17

1.9

1.8

17624.5

19287.7

e6/l

0.05

128

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

147

654

2.27

19.01

1.3

—

(3049242) von Willebrand panel - Platelet poor plasma

11.13

18.87

2.0

2.1

—

(3012565) Volume of 24 hour Urine

101

379

2.68

18.84

2.0

2.2

1797.5

1947.4

0.70

333

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.34

18.79

1.2

—

(3016038) Potassium [Moles/volume] in Urine

128

540

2.39

18.71

1.6

1.2

32.2

34.4

mmol/l

0.62

111

466

(3019225) pH of Specimen

1048

7904

1.37

18.59

7.2

4.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

284

1610

1.79

18.56

1.3

1.2

47.5

42.1

u/ml

0.26

164

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

283

2.95

18.51

1.5

1.4

64.2

65.1

0.08

227

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

125

525

2.40

18.46

1.5

1.4

3.3

1.2

u/ml

0.68

242

(3023487) Leukocytes [#/volume] in Peritoneal fluid

266

2.99

18.03

2.1

2204.5

3703.2

e6/l

0.18

181

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

359

2191

1.66

18.00

3.1

2.2

5941.1

4970.2

u/l

0.15

116

846

(40761511) CBC panel - Blood by Automated count

8405

80969

1.35

17.58

27.6

13.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

179

3.42

17.46

1.2

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

277

2.90

17.39

4.2

2.4

185.2

144.0

nmol/l

2.69

237

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

120

4.02

17.31

4.7

5.6

—

(40768443) Skin Pathology biopsy report

526

3548

1.51

17.19

1.3

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

108

4.18

17.13

1.2

1.4

505414.2

153853.5

nmol/l

0.30

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

8.48

17.12

2.4

1.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

7.52

16.94

2.3

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

484

3220

1.53

16.88

7.4

5.1

1.8

1.6

2.06

454

3011

(3039162) Centromere protein B Ab [Units/volume] in Serum

190

981

1.96

16.68

1.3

46.7

55.9

u/ml

0.21

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

318

2.72

16.56

3.1

2.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

248

2.96

16.44

1.2

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

434

6476

0.65

16.31

1.7

—

(3047181) Lactate [Moles/volume] in Blood

385

2455

1.59

16.20

8.6

6.1

1.4

1.3

mmol/l

1.12

337

2162

(3009871) Measles virus Ab [Titer] in Serum

245

2.95

16.17

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1623

13254

1.27

16.05

1.6

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

364

2.57

16.02

1.2

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

121

536

2.27

15.88

1.4

13.0

12.8

umol/l

0.05

116

507

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

336

2085

1.63

15.82

1.2

1.3

175.6

221.0

miu/ml

1.44

108

943

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

162

3.41

15.69

5.3

4.6

71.2

85.6

u/l

0.16

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

394

2.48

15.48

1.2

1.1

—

(3019977) pH of Arterial blood

104

437

2.40

15.42

2.7

2.8

7.4

1.76

153

(40761539) Cells [Type] in Urine sediment by Light microscopy

199

3.13

15.41

1.2

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

210

3.06

15.33

1.2

1.3

236.8

269.6

ug/l

0.07

118

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

152

748

2.05

15.31

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7520

71686

1.24

15.25

5.5

4.8

2.3

2.1

mu/l

0.29

6967

65578

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

411

2.42

15.08

1.3

1.1

—

(3033799) Differential panel - Peritoneal fluid

239

2.90

15.04

1.6

2.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1545

12644

1.27

14.91

1.3

17.4

12.2

u/ml

1.46

502

4849

(3018738) Hemoglobin F/Hemoglobin.total in Blood

5.76

14.90

2.1

3.5

4.2

5.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

739

5456

1.38

14.87

2.9

2.1

12.0

12.6

nmol/l

1.24

661

4779

(3007930) Methemoglobin/Hemoglobin.total in Blood

468

3182

1.50

14.74

7.7

5.2

1.0

0.9

0.47

438

2983

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

103

3.99

14.73

4.3

5.8

42.1

45.0

ug/min

0.13

(3017569) Oxygen content in Arterial blood

377

2.45

14.44

2.4

2.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

119

3.71

14.28

1.9

3.0

75.8

30.1

mg/l

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

267

4297

0.61

14.08

1.5

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.40

14.08

3.3

5.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

356

2308

1.56

13.99

1.8

1.7

334.9

305.5

mu/l

0.66

323

2094

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.05

13.95

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

332

2.51

13.73

2.9

1.8

27.3

28.8

umol/l

0.42

321

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

236

2.81

13.62

1.2

1.1

76.2

91.2

2.69

108

(3016750) Collection duration of Urine

101

447

2.27

13.36

2.1

2.2

528.8

495.1

min

2.36

337

(3044007) Cell count panel - Peritoneal fluid

217

2.87

13.31

1.8

2.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

229

2.81

13.20

1.2

76.3

90.1

1.66

109

(3004616) Nuclear Ab [Presence] in Serum

173

938

1.86

13.20

1.4

1.3

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

406

2.33

13.17

15.0

11.6

0.6

mmol/l

0.13

369

(3023383) Lactate [Moles/volume] in Pleural fluid

242

2.74

13.01

1.3

3.6

3.4

mmol/l

0.30

214

(3024928) Oxygen saturation in Venous blood

262

1608

1.65

12.95

8.0

3.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

226

2.80

12.94

1.3

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

199

2.93

12.92

2.4

1.7

—

(3009508) Creatinine [Moles/volume] in Urine

2827

24920

1.19

12.92

3.7

3.2

7.2

7.5

mmol/l

3.06

2336

20894

(3043409) Potassium [Moles/volume] in Arterial blood

353

2328

1.54

12.88

5.4

4.3

3.9

mmol/l

0.17

322

2190

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5203

48279

1.17

12.71

3.3

2.9

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

326

2121

1.56

12.65

1.2

1.4

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

11.83

12.63

1.1

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

5.80

12.24

1.1

1.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1125

9060

1.27

12.24

2.0

1.7

1.5

2.71

963

7906

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

279

2.56

12.23

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

312

2027

1.56

12.19

1.1

1.2

—

(3044927) Protein electrophoresis panel - Urine

148

784

1.90

12.17

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

123

612

2.02

12.12

1.2

57.6

52.7

u/ml

—

(3044242) Glucose [Moles/volume] in Arterial blood

379

2.31

11.99

2.3

1.9

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

6.26

11.99

4.9

3.9

—

(3021788) Differential panel - Synovial fluid

233

1417

1.66

11.97

1.8

1.5

—

(3018291) Platelet Ab [Presence] in Serum

12.01

11.73

1.2

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

30.04

11.63

1.0

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

4.59

11.62

5.5

3.9

2.1

2.6

mg/l

0.70

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

119

595

2.01

11.59

1.2

57.8

76.3

u/ml

0.47

(3012516) Albumin [Mass/volume] in Urine

2645

23354

1.18

11.59

3.6

3.3

1037.1

392.1

mg/l

4.56

1723

14708

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

119

599

2.00

11.39

1.2

18.8

37.3

u/ml

0.59

(3011985) Renin [Units/volume] in Plasma

185

1073

1.74

11.35

1.7

1.4

76.6

72.4

mu/l

0.07

163

955

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

126

650

1.95

11.25

2.2

2.4

18.0

18.6

nmol/l

0.19

119

615

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

143

773

1.86

11.09

1.1

—

79.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

189

1111

1.72

11.06

1.4

1.3

0.7

2.0

nmol/l

0.67

181

1069

(3023410) Appearance of Cerebral spinal fluid

143

774

1.86

11.05

3.4

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

224

2.64

10.94

1.2

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

115

581

1.99

10.91

1.2

68.0

40.8

mg/l

0.67

489

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

5.95

10.84

5.2

3.6

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

197

2.75

10.81

1.3

1.4

23.2

24.8

0.14

161

(3002814) Trichinella spiralis Ab [Titer] in Serum

28.03

10.71

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

174

1011

1.73

10.63

1.3

427.0

318.0

pmol/l

0.67

135

757

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

131

700

1.88

10.56

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

156

2.96

10.53

1.2

71.9

75.6

0.20

(3034426) Prothrombin time (PT)

282

2.42

10.52

1.1

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

167

2.88

10.50

2.0

1.9

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.79

10.45

1.4

1.2

—

(4027681)

435

2.13

10.45

1.4

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

116

599

1.95

10.36

1.3

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

174

2.83

10.33

3.5

2.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

810

6395

1.29

10.28

4.1

2.6

57.5

65.8

ml/min/173m2

7.92

402

2508

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

106

532

2.00

10.27

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

23.36

10.23

1.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

479

2.06

10.21

2.0

1.5

6.8

5.9

u/l

0.64

405

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

110

562

1.97

10.14

1.1

350.3

269.2

mg/l

0.54

490

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

117

611

1.93

10.12

1.0

317.8

288.1

mg/l

2.04

101

547

(4281824)

154

881

1.76

9.97

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

156

2.89

9.93

1.2

72.6

79.1

0.51

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

315

2.30

9.90

1.1

1443.7

1501.3

miu/ml

0.17

315

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

264

1735

1.54

9.88

1.6

1.4

219.2

161.6

pmol/l

0.79

257

1694

(3039000) Anion gap in Blood

266

1753

1.53

9.83

10.4

7.1

11.2

mmol/l

0.02

242

1570

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

312

2126

1.48

9.83

1.5

1.4

—

(3018572) Chloride [Moles/volume] in Blood

266

1754

1.53

9.80

10.4

7.1

105.5

105.1

mmol/l

0.54

242

1571

(3003338) MCHC [Mass/volume]

6317

66147

0.86

9.70

43.2

18.2

330.7

332.4

g/l

33.30

6279

65661

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

170

1008

1.70

9.70

1.4

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

7378

70993

1.18

9.65

33.7

15.2

38.7

39.7

15.97

4982

50721

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

184

1116

1.66

9.64

1.4

1.3

0.2

0.3

nmol/l

1.58

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.57

9.62

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

404

2.11

9.57

1.6

1.8

1.9

3.1

u/field

1.05

282

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

399

2.12

9.47

1.2

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

123

3.10

9.45

1.7

1.6

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

109

571

1.92

9.38

1.3

1.2

17.2

5.9

u/ml

0.46

(3044009) aPTT.lupus sensitive (LA screen)

4.22

9.36

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

401

2.10

9.36

1.6

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

163

968

1.70

9.27

1.8

1.6

58.7

58.1

0.07

105

615

(3027456) Digoxin [Moles/volume] in Serum or Plasma

227

1465

1.56

9.24

3.4

3.0

0.8

nmol/l

0.18

167

1110

(3020682) Albumin/Creatinine [Ratio] in Urine

2732

24547

1.16

9.16

4.5

4.0

14.3

9.3

mg/mmol

4.07

1708

15471

(3004775) Volume in Urine collected for unspecified duration

117

633

1.86

9.14

2.2

713.9

648.9

0.93

430

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.50

9.04

1.2

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

227

1473

1.55

9.03

1.9

1.8

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

842

6792

1.26

8.97

2.4

2.3

8.9

7.3

ug/l

0.69

707

5914

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

280

2.29

8.85

1.2

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

491

3705

1.34

8.64

1.4

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

4.76

8.57

1.2

1.0

1.2

1.0

u/field

0.30

(3011397) Hemoglobin [Presence] in Urine by Test strip

2077

18357

1.17

8.55

4.2

3.7

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

170

2.65

8.51

1.2

1.4

21.6

26.3

g/l

1.11

134

(3000492) Spirometry study

903

7400

1.24

8.38

1.7

1.5

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

5.78

8.32

1.4

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

128

2.90

8.25

1.9

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

128

2.90

8.25

1.9

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

128

2.90

8.25

1.9

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

3.82

8.22

2.0

2.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

123

2.93

8.20

1.2

3.2

1.7

mmol/l

0.35

(44786800) Granulocytes/100 leukocytes in Body fluid

102

3.14

8.20

1.3

39.5

24.1

1.12

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.34

8.19

1.1

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

5.01

8.13

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

192

2.51

8.11

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

192

2.51

8.11

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

192

2.51

8.11

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

192

2.51

8.11

1.0

1.1

—

(3024316) Viscosity of Plasma

4.74

8.10

2.7

1.5

1.8

1.7

mpas

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

377

2.05

8.08

1.0

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

305

2.17

8.04

1.1

1357.2

394.5

ng/l

0.41

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

109

3.03

7.98

1.5

1.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

124

714

1.75

7.94

1.7

1.5

32.0

30.8

0.11

436

(3049717) Cytology report of Urine Cyto stain

399

2956

1.37

7.94

2.5

2.7

—

(3001186) Copper [Moles/volume] in Serum or Plasma

189

2.49

7.86

1.4

1.2

16.8

16.7

umol/l

0.06

170

(3020961) Endomysium IgA Ab [Titer] in Serum

478

3648

1.33

7.82

1.1

52.5

187.8

titre

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

342

2.08

7.80

1.1

96.1

95.6

0.03

267

(3028707) Methadone [Presence] in Urine by Screen method

178

1133

1.58

7.76

4.4

2.7

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

121

697

1.75

7.75

1.7

1.4

2.5

4.2

ug/l

2.28

599

(3020717) Zinc [Moles/volume] in Serum or Plasma

405

1.98

7.68

1.7

1.5

20.9

24.5

umol/l

0.58

385

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

6.67

7.60

5.2

6.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

273

1911

1.44

7.58

1.8

1.6

14895.0

13285.4

e6/l

0.26

200

1378

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

4.23

7.46

1.1

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

220

2.33

7.35

1.1

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

+∞

7.29

1.6

0.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

338

2.05

7.28

1.5

2.2

143.7

138.3

umol/l

0.03

190

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

127

2.76

7.20

2.1

1.6

0.1

0.2

nmol/l

0.81

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

314

2.08

7.12

1.5

1.2

—

(3041354) Potassium [Moles/volume] in Venous blood

149

929

1.61

7.12

3.6

2.3

4.1

mmol/l

0.06

149

917

(3035285) Chloride [Moles/volume] in Venous blood

149

929

1.61

7.12

3.6

2.3

105.2

105.6

mmol/l

0.36

149

917

(3033086) Enterovirus NOS Ab [Titer] in Serum

5.66

7.06

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

168

1086

1.56

6.90

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

233

2.24

6.89

2.5

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

145

908

1.61

6.83

3.6

2.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

171

1114

1.54

6.80

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

208

1413

1.48

6.79

1.5

1.3

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

127

2.68

6.64

1.6

1.4

9.0

8.6

0.04

(3019174) dRVVT (LA screen)

3.44

6.55

1.3

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

292

2.06

6.49

1.0

1.1

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

5.21

6.48

1.2

1.0

1.3

0.9

u/field

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.01

6.48

1.1

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

157

1016

1.55

6.45

1.4

1.3

28.2

28.5

u/l

0.05

137

827

(3024869) Neuronal Ab [Presence] in Serum

154

2.47

6.32

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

210

2.24

6.30

1.7

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

567

1.74

6.27

2.0

2.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

400

1.88

6.26

1.1

u/l

0.03

183

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

656

5373

1.24

6.15

2.4

31.9

23.7

au/ml

0.36

285

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

122

2.63

6.04

1.9

3.1

—

(3012898) Urea [Moles/volume] in Urine

3.08

6.02

1.0

1.4

159.8

161.7

mmol/l

0.02

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

263

1915

1.38

5.93

1.8

4.2

4.4

iu/l

0.15

105

676

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.29

5.84

1.4

1.6

1.1

ml/s/173m2

1.00

(3014891) Appearance of Pleural fluid

107

2.72

5.83

1.7

1.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

476

1.77

5.81

1.5

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.78

5.80

1.3

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

212

2.18

5.76

1.3

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

313

1.95

5.75

1.2

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

478

1.76

5.73

1.4

1.3

23.3

64.5

titre

—

(3014271) Vancomycin [Susceptibility]

384

1.86

5.72

3.2

2.9

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

496

1.74

5.61

1.4

1.3

778.0

327.1

titre

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

208

2.17

5.60

1.3

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

622

5120

1.23

5.58

1.2

111.5

144.0

iu/ml

1.29

189

1896

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

216

2.14

5.51

1.2

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

274

2034

1.36

5.51

2.1

1.8

39.8

41.6

nmol/l

0.55

262

1968

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1386

0.59

5.50

1.5

—

(3044941) Cell count panel - Synovial fluid

177

1220

1.46

5.45

1.6

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

398

1.82

5.43

1.3

1.7

6.0

6.1

mmol/24h

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1589

0.62

5.39

1.5

1.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.55

5.31

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

206

1469

1.41

5.29

2.4

1.9

184.3

201.4

pmol/l

1.60

199

1384

(3022621) pH of Urine by Test strip

626

5191

1.22

5.24

3.2

3.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

374

1.82

5.23

1.7

1.5

5.5

4.0

0.51

(36660697) Celiac disease serology panel - Serum

738

6222

1.20

5.21

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

215

2.10

5.18

1.3

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.47

5.16

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

168

1160

1.46

5.15

1.0

1.1

14.2

12.9

au/ml

—

(3011648) Oxygen content in Venous blood

100

616

1.63

5.14

11.4

3.1

9.5

11.2

3.98

100

616

(3050794) Legionella sp Ab [Presence] in Serum

3.00

5.09

1.3

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

3.08

5.05

1.5

2.0

65.9

60.4

0.21

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

5.27

5.03

1.2

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.40

5.02

1.0

—

(3008037) Lactate [Moles/volume] in Venous blood

228

1671

1.37

5.00

4.9

3.2

1.5

1.6

mmol/l

0.74

223

1623

(3045716) Anion gap in Serum or Plasma

359

1.82

4.95

1.7

2.2

8.5

9.4

mmol/l

1.48

276

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.12

4.90

5.1

9.5

—

(3007461) Platelets [#/volume] in Blood

8780

86582

1.20

4.87

49.2

20.8

260.0

250.7

e9/l

11.57

8645

84339

(4198724)

311

1.87

4.86

1.7

2.4

—

(3011897) Casein IgE Ab [Units/volume] in Serum

125

2.40

4.78

1.2

1.3

1.5

4.3

u/ml

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.16

4.75

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

197

2.09

4.69

1.3

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

139

2.31

4.66

1.2

1.1

7.9

4.7

pmol/l

—

(3010937) Rubella virus Ab [Presence] in Serum

3.69

4.64

1.0

1.1

—

(3035941) MCH [Entitic mass]

8781

86630

1.20

4.62

48.9

20.7

30.5

30.3

12.34

8705

85434

(44806071)

103

2.53

4.61

1.2

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

587

4903

1.21

4.60

1.3

32.5

52.9

au/ml

1.62

212

(3024731) MCV [Entitic volume]

8781

86635

1.20

4.59

48.9

20.7

92.2

91.0

55.74

8705

85440

(3002523) Influenza virus A Ag [Presence] in Specimen

162

1138

1.43

4.58

1.3

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.97

4.54

9.5

5.5

—

(3026361) Erythrocytes [#/volume] in Blood

8781

86644

1.19

4.53

49.1

20.8

4.3

4.5

e12/l

108.43

8623

84160

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

251

1899

1.33

4.52

2.8

2.4

155.4

101.2

ug/min

0.86

138

1141

(3045414) Leukocytes [Presence] in Urine

441

3584

1.24

4.52

2.2

1.9

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

174

2.13

4.48

2.5

2.9

130.3

138.1

ng/l

0.08

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.59

4.48

2.3

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.65

4.47

1.2

1.0

—

(3010813) Leukocytes [#/volume] in Blood

8781

86659

1.19

4.44

49.2

20.8

7.5

6.7

e9/l

19.05

8626

84151

(3000963) Hemoglobin [Mass/volume] in Blood

8781

86663

1.19

4.41

49.4

20.9

129.9

135.3

g/l

135.79

8702

85469

(3003740) Influenza virus B Ag [Presence] in Specimen

161

1139

1.42

4.40

1.3

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.62

4.38

1.0

1.2

20.5

21.7

u/l

0.13

(3035611) Eosinophils/100 leukocytes in Synovial fluid

3.09

4.35

1.2

1.5

0.3

0.8

0.80

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.73

4.34

1.3

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

420

1.70

4.33

1.5

1.4

1.5

1.2

nmol/l

1.24

314

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

218

1.98

4.28

1.8

1.1

—

(3011288) Drugs identified in Urine by Screen method

226

1699

1.34

4.27

4.7

2.9

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

290

1.83

4.22

1.5

14.1

16.0

pmol/l

1.40

240

(3030313) Adrenal Ab [Titer] in Serum

3.14

4.20

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.42

4.18

2.3

1.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

565

1.58

4.13

1.8

1.6

28.8

23.1

u/ml

—

127

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

364

2929

1.25

4.11

1.6

1.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1284

0.64

4.11

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

141

2.20

4.10

1.8

1.6

122.3

134.0

ng/l

0.17

141

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1283

0.64

4.09

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1283

0.64

4.09

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

204

2704

0.75

4.05

1.9

1.7

6.7

3.6

mg/l

1.42

164

1918

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.19

4.05

1.1

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1279

0.64

4.04

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

136

2.21

4.00

3.0

2.0

16.8

17.8

umol/l

0.18

136

(3001729) Color of Synovial fluid

2.77

3.84

1.2

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

868

9861

0.87

3.82

12.3

6.9

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

108

730

1.48

3.80

1.4

1.3

38391.9

91120.4

e6/l

1.26

495

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

269

2115

1.28

3.72

1.1

12.9

7.6

u/ml

0.35

244

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1082

0.63

3.70

1.5

—

(3024263) Appearance of Synovial fluid

410

1.64

3.65

2.2

1.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

253

1.82

3.65

3.6

2.7

28.6

28.2

umol/l

0.06

188

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1813

19652

0.90

3.63

4.0

4.3

22.1

21.9

0.21

871

9707

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.47

3.62

2.1

2.6

0.4

0.6

u/field

0.69

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

103

698

1.48

3.60

1.2

1.3

1.4

1.5

nmol/l

0.38

627

(3051387) C reactive protein [Mass/volume] in Capillary blood

218

1679

1.31

3.55

4.2

3.4

30.1

26.4

mg/l

0.82

152

1039

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.39

3.55

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1046

0.63

3.54

1.5

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

251

1970

1.28

3.54

3.8

2.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

105

2.29

3.51

1.3

1.1

—

(3005033) Fetal Nuchal fold Thickness US

1043

0.63

3.50

1.5

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

150

1096

1.37

3.48

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

145

1054

1.38

3.47

1.1

5.8

3.7

u/ml

0.41

466

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.61

3.46

2.4

1.9

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

355

1.67

3.45

1.7

8.1

5.4

nmol/l

0.27

293

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

237

1.82

3.41

2.7

2.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

237

1.82

3.41

2.7

2.9

—

(3001019) Free T4 and TSH panel - Serum or Plasma

299

3687

0.80

3.39

1.6

1.7

—

(3045424) Erythrocytes [Presence] in Urine

176

1325

1.33

3.38

1.7

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

111

774

1.44

3.38

2.2

2.1

15.4

8.1

umol/l

1.25

555

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

167

1.98

3.37

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

7.00

3.36

1.1

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2222

20727

1.09

3.36

1.8

1.6

1.4

mmol/l

9.36

1816

17371

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.36

3.31

1.3

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

148

2.03

3.29

1.6

1.4

—

(44813793)

533

1.52

3.29

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

479

1.55

3.24

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

4.74

3.23

1.1

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

602

1.48

3.19

1.3

10.9

12.0

mmol/l

0.77

168

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.36

3.14

1.2

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

124

2.10

3.13

1.4

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

495

4235

1.18

3.07

2.5

2.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

255

1.73

2.99

1.0

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.29

2.99

3.8

3.3

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

2.75

2.98

1.2

1.1

1.4

5.5

u/l

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.40

2.96

1.1

1.2

2.1

1.7

umol/24h

0.55

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

127

2.05

2.96

1.7

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.54

2.95

1.9

3.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7711

78358

0.91

2.94

5.2

4.9

2.6

2.8

mmol/l

29.57

7087

72117

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

611

1.44

2.80

1.8

2.0

3.0

1.9

u/field

0.79

239

(4034850)

202

2542

0.79

2.80

16.5

9.8

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

172

1.86

2.80

2.7

1.8

2.6

1.9

ug/l

0.68

(3033923) Metanephrine [Moles/time] in 24 hour Urine

166

1.87

2.75

1.2

1.1

0.7

umol/24h

0.08

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

145

1.93

2.74

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

111

2.07

2.72

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

189

1.80

2.69

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

154

1.89

2.64

1.3

1.2

1.8

1.7

mmol/l

0.16

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.33

2.64

1.0

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

235

1.71

2.63

2.1

2.2

9.6

9.5

mg/l

0.06

191

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

504

1.47

2.63

1.0

1.1

7.0

10.5

iu/ml

0.46

112

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7511

76325

0.92

2.60

4.7

4.4

1.4

1.5

mmol/l

61.79

6901

70236

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

305

1.61

2.60

2.6

2.5

—

(4010399)

651

5765

1.14

2.59

1.6

1.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

192

1.77

2.57

1.4

1.6

0.5

0.4

ug/l

0.58

121

(3025018) Bordetella pertussis Ab [Titer] in Serum

458

1.49

2.56

1.2

—

(3016879) Cocaine [Presence] in Urine

284

2360

1.21

2.51

3.6

2.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.20

2.46

1.2

1.1

0.3

0.4

u/ml

0.14

(3017315) Amylase [Enzymatic activity/volume] in Urine

416

1.49

2.40

1.6

1.2

408.5

305.6

u/l

0.35

380

(3000764) Benzodiazepines [Presence] in Urine

302

2537

1.20

2.39

3.5

2.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

6.25

2.37

1.6

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

321

1.56

2.36

4.2

1.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.42

2.36

1.0

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.61

2.35

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

387

1.50

2.31

1.3

1.1

—

(3028300) Cannabinoids [Presence] in Urine

303

2556

1.19

2.30

3.6

2.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

155

1.81

2.29

3.4

2.5

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.37

2.29

1.4

1.8

12.7

18.1

—

(3025315) Body weight

2.37

2.29

6.1

4.4

—

(3045462) Protein/Creatinine [Ratio] in Urine

2.12

2.28

7.1

5.1

141.5

62.0

g/mol

0.31

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

106

1.98

2.25

1.3

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

725

1.36

2.24

4.1

4.8

48.9

77.0

u/ml

0.55

211

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.11

2.22

5.0

5.2

390.7

398.5

umol/l

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.34

2.21

1.3

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

128

1.88

2.20

1.0

1.1

—

(3027008) Opiates [Presence] in Urine

301

2550

1.19

2.20

3.5

2.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.78

2.20

1.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.62

2.18

2.0

3.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.24

2.17

1.3

1.0

—

(3000330) Specific gravity of Urine by Test strip

454

3979

1.15

2.15

4.5

3.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1314

14121

0.92

2.15

2.8

3.0

0.7

0.8

ug/l

0.30

895

9527

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.30

2.14

1.1

1.3

—

47.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.30

2.14

1.1

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

5.00

2.07

1.6

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.08

2.06

1.2

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.98

2.04

1.2

1.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7584

76877

0.93

2.04

4.8

4.4

4.5

4.7

mmol/l

41.95

7035

71177

(3034614) HLA Ag [Interpretation]

4.00

2.04

1.5

1.3

—

(3006270) Folate [Moles/volume] in Blood

670

1.35

2.01

1.1

1.2

323.1

355.0

nmol/l

0.75

562

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

111

1.89

2.00

1.3

322.7

335.6

u/l

0.01

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.81

2.00

1.6

1.1

313.3

277.3

nmol/l

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

451

1.42

1.98

1.1

5.7

9.7

nmol/l

0.38

102

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.14

1.98

1.3

1.2

51.2

114.0

ug/l

—

(3026726) Creatinine [Moles/volume] in Specimen

2.14

1.98

1.9

2.3

228.5

462.2

umol/l

0.42

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

899

9786

0.91

1.97

4.4

4.5

31.1

32.5

3.54

658

6647

(1761482) Bacteria [#/volume] in Urine by Culture

236

1980

1.20

1.96

5.0

4.2

—

(3019150) Specific gravity of Urine by Refractometry

1782

16829

1.07

1.93

4.9

4.1

1.0

kg/l

0.66

283

2523

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

203

1.63

1.91

1.4

1.3

113.9

125.4

nmol/l

0.16

150

(40765089) Chromosome analysis panel - Blood by G-banded

188

1.65

1.90

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

173

1.68

1.89

2.5

2.3

7.6

7.8

mmol/l

0.08

105

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

251

1.56

1.88

1.3

1.2

103.4

110.2

0.50

219

(3027944) Amphetamines [Presence] in Urine

292

2509

1.17

1.85

3.4

2.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

269

1.53

1.83

1.3

1.2

0.3

g/l

1.21

216

(3014051) Protein [Presence] in Urine by Test strip

221

1857

1.19

1.83

2.7

2.2

—

(3042517) Benzodiazepines panel - Urine

2.12

1.81

2.6

2.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

183

1.64

1.81

1.3

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.92

1.79

1.2

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

256

1.53

1.75

2.5

3.6

7.4

7.9

mg/l

0.22

207

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

187

2237

0.83

1.73

1.4

1.5

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

2.92

1.72

1.1

1.3

1.5

1.4

—

(3002619) Bacteria identified in Specimen by Culture

155

1.68

1.72

1.2

—

(40761535) Cells panel - Urine sediment

710

6492

1.10

1.70

4.3

3.6

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

118

1.78

1.69

1.5

1.8

34.8

54.6

pmol/l

0.74

(40768800) Prostate Pathology biopsy report

125

1553

0.80

1.69

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

319

0.56

1.67

1.5

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.38

1.67

1.2

1.0

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

235

1.53

1.67

1.3

56.2

53.9

0.13

196

(40757494) Bilirubin.total [Moles/volume] in Blood

442

1.38

1.66

2.5

64.4

23.3

umol/l

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

353

1.42

1.59

2.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

703

6457

1.10

1.55

1.9

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

186

1567

1.19

1.54

2.5

1.9

1.2

0.8

nmol/l

4.01

157

1323

(3049233) Organic acids panel - Urine

3.33

1.52

1.0

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

3.33

1.52

2.0

2.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

433

1.36

1.52

1.0

—

(3020650) Glucose [Presence] in Urine

193

1.56

1.50

1.2

1.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

116

1.73

1.48

1.2

1.3

73.4

53.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.22

1.46

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

488

1.33

1.46

5.5

6.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.73

1.43

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.79

1.42

12.6

9.0

—

(3020491) Glucose [Moles/volume] in Blood

586

1.30

1.42

1.6

2.0

7.1

6.7

mmol/l

0.74

403

(3039443) Prostate specific Ag panel - Serum or Plasma

107

1321

0.81

1.41

1.3

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1253

11825

1.07

1.41

1.5

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.18

1.39

1.3

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.94

1.36

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

112

1.70

1.35

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.75

1.34

1.8

2.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

211

2434

0.86

1.33

1.6

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

350

1.37

1.32

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.89

1.28

1.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.94

1.27

1.6

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

344

1.37

1.27

2.4

2.2

60.6

55.5

umol/l

0.42

281

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

518

1.30

1.26

2.1

1.8

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

1.82

1.25

1.1

1.4

14.2

20.6

pmol/l

0.35

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

791

8467

0.93

1.24

1.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1034

0.80

1.23

1.3

7.5

7.4

mmol/l

0.08

767

(3040893) Potassium [Moles/volume] in Capillary blood

2.31

1.18

1.7

2.3

4.1

4.5

mmol/l

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

239

1.42

1.17

2.2

3.0

65.4

133.6

au/ml

—

(3025130) Human papilloma virus identified in Specimen

114

947

1.21

1.17

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

767

7175

1.08

1.15

2.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7620

75457

1.05

1.15

5.0

4.6

6.0

5.9

mmol/l

2.91

6950

68780

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

529

0.74

1.12

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.90

1.12

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

159

1.51

1.11

1.3

—

(3022475) Manganese [Moles/volume] in Blood

1.96

1.11

1.3

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

763

1.22

1.10

1.3

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.38

1.09

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

218

1.42

1.08

1.1

0.5

2.9

u/ml

1.65

121

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

210

1.43

1.07

1.3

36.5

36.2

0.02

141

(3009015) Lactate [Moles/volume] in Synovial fluid

1.69

1.07

1.3

1.2

5.5

6.5

mmol/l

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

203

1.43

1.04

9.2

7.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

106

1.60

1.02

1.1

—

(1002224) Polysomnography panel

277

3069

0.90

0.99

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.80

0.98

1.3

1.4

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.17

0.98

5.2

2.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

727

6844

1.07

0.95

1.5

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

191

1.41

0.94

1.1

1.2

308.8

270.0

pmol/l

0.21

136

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.78

0.94

1.1

7.8

14.7

u/l

0.65

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

2.22

0.93

6.7

6.4

2.4

1.3

mg/l

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

171

0.58

0.91

1.0

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

195

0.61

0.90

1.3

1.6

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.07

0.89

1.2

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

177

1.41

0.88

1.4

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

178

1.41

0.86

9.3

7.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.82

0.85

1.0

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

548

0.78

0.85

1.0

47.2

44.7

ng/l

0.17

378

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.67

0.85

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

545

0.79

0.82

1.0

701.4

714.9

ng/l

0.09

370

(4146454)

863

0.83

0.82

2.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.64

0.81

1.2

1.7

43.9

42.3

umol/l

0.07

(3013139) Helicobacter pylori Ag [Presence] in Stool

560

5261

1.07

0.81

1.3

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

544

0.79

0.81

1.0

322.0

333.8

ng/l

0.13

384

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.61

0.81

2.2

2.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

617

1.20

0.81

1.3

1.5

1.3

promille

0.08

467

(4094501)

190

2118

0.89

0.80

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

830

1.17

0.79

1.5

—

(37021550) Renin [Units/volume] in Plasma --upright

181

1.38

0.79

1.3

91.8

70.6

mu/l

0.21

136

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

0.1

—

(40758358) Immune stain study

1.82

0.79

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

803

1.17

0.79

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

233

2559

0.91

0.76

1.9

1.8

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.70

0.75

1.0

2.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.70

0.75

1.1

1.5

524.1

320.7

umol/24h

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

426

3979

1.07

0.74

1.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.08

0.74

1.0

1.2

—

mmol/l

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.67

0.74

1.0

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.67

0.72

1.2

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

117

1.45

0.71

1.2

1.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

264

1.29

0.71

1.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

161

1442

1.12

0.71

1.2

1.1

1.6

1.5

u/ml

0.03

602

(3007463) Buprenorphine [Presence] in Urine

1.92

0.70

3.6

6.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7225

71691

1.03

0.69

6.3

5.8

39.9

39.8

mmol/mol

0.14

6649

66277

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.53

0.68

1.1

1.2

9.0

9.1

mg/l

0.03

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

835

0.85

0.68

1.1

1.0

0.4

0.3

u/ml

0.07

211

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.85

0.68

1.2

1.3

309.7

447.1

nmol/l

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

351

0.77

0.66

1.1

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

132

1178

1.12

0.64

1.1

4.0

1.7

u/ml

0.55

296

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.59

0.61

1.6

2.3

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

113

1.42

0.61

1.2

1.1

68.4

76.4

ug/l

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.46

0.57

2.2

2.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

103

1159

0.89

0.57

1.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.62

0.55

7.7

7.3

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

1.46

0.54

1.3

1.1

0.9

1.6

u/ml

0.26

(3008898) HLA-B27 [Presence]

271

2534

1.07

0.52

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

475

0.84

0.48

1.1

1.3

—

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

190

1.26

0.47

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

111

1006

1.10

0.46

2.8

2.1

26.8

23.9

mg/l

0.17

263

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.59

0.45

1.2

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

148

1363

1.09

0.44

1.7

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.61

0.43

1.8

1.2

1.7

1.8

mg/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

266

2509

1.06

0.42

1.6

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

406

1.16

0.42

2.3

2.1

63.7

165.5

ug/min

0.74

(3025296) Carrot IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

3.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

240

1.21

0.41

1.4

1.2

41.8

38.3

g/l

0.74

129

(3022670) pH of Venous cord blood

0.00

0.41

0.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

402

0.85

0.41

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

314

1.18

0.41

3.6

2.5

—

(4038314)

1.47

0.40

1.0

1.2

—

(4133840)

195

1.23

0.40

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

138

1277

1.08

0.39

1.3

1.2

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.39

0.0

1.0

—

11950.0

—

(3017509) Phencyclidine [Presence] in Urine

1.39

0.36

1.4

1.6

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.40

0.35

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

128

1.25

0.31

1.3

1.1

3.5

7.7

u/ml

0.34

(3000285) Sodium [Moles/volume] in Blood

110

1.27

0.31

1.2

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

316

1.14

0.29

2.0

1.8

—

(4211845)

430

1.12

0.28

2.7

3.4

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.29

0.28

1.5

1.3

—

577.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.25

0.27

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

864

0.93

0.26

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

104

1.25

0.26

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

2658

26859

0.99

0.26

3.2

2.9

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

234

1.15

0.26

1.2

1.5

9.8

8.7

ug/l

0.51

234

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.70

0.26

1.0

3.5

3.3

kpa

—

(3015183) Erythrocyte sedimentation rate

339

1.12

0.25

1.3

—

(4024509)

799

0.93

0.25

1.8

1.5

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

137

0.80

0.24

1.1

66.1

56.0

u/ml

0.22

129

(3015076) Soybean IgE Ab [Units/volume] in Serum

389

1.11

0.23

1.1

1.0

0.3

1.6

u/ml

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

153

1.18

0.22

3.2

3.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

153

1.18

0.22

6.3

6.1

—

(3051101) Glucose [Moles/volume] in Cord blood

135

0.81

0.22

3.6

6.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

381

3918

0.97

0.21

1.8

1.9

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.19

0.21

1.2

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

135

1.19

0.21

10.6

7.4

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

1.9

—

(3051593) INR in Capillary blood by Coagulation assay

364

1.10

0.20

11.8

10.9

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.20

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.25

0.20

1.2

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

137

1.17

0.18

1.7

2.9

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

353

0.91

0.18

1.1

9.6

5.0

u/ml

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

121

1262

0.96

0.16

1.1

0.4

1.0

u/ml

2.43

553

(3000034) Microalbumin [Mass/volume] in Urine

750

1.05

0.15

3.8

3.0

102.4

49.0

mg/l

0.70

555

(3026470) Cobalt [Mass/volume] in Blood

524

0.93

0.15

1.9

2.0

3.4

3.8

ug/l

0.24

460

(42870560) Thyrotropin [Units/volume] in Cord blood

1.11

0.15

1.0

7.8

8.3

mu/l

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7359

73743

0.99

0.14

4.4

4.0

1.4

1.3

mmol/l

22.09

6735

67347

(3025577) Chromium [Mass/volume] in Blood

510

0.94

0.13

1.9

2.1

2.6

ug/l

0.03

425

(3037556) Urate [Mass/volume] in Serum or Plasma

242

0.91

0.13

1.5

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

437

0.94

0.12

1.1

11.3

1.7

u/ml

0.44

120

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

157

0.89

0.11

1.2

1.3

0.8

102.5

mg/l

—

119

(3006462) Nitrate [Presence] in Urine

398

1.06

0.10

2.6

3.5

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.09

0.09

1.0

2.5

3.3

u/ml

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.83

0.08

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

0.84

0.07

1.0

—

-2.6

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.84

0.07

1.0

7.5

7.4

kpa

—

(3006598) pH of Arterial cord blood

0.84

0.07

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

118

1208

0.98

0.07

1.1

84.5

8223.6

iu/ml

0.54

290

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

100

1025

0.98

0.07

1.8

1.7

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.83

0.07

1.0

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.86

0.06

1.4

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

518

0.97

0.06

1.8

1.3

997.1

125.4

pmol/l

0.47

153

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2454

24616

1.00

0.06

4.8

5.0

3.9

3.3

ug/l

0.47

2156

22082

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

306

3090

0.99

0.05

1.7

1.9

—

(4015189)

230

1.04

0.03

2.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

430

1.02

0.02

1.1

1.9

2.7

u/ml

0.21

133

(3014133) Dog dander IgE Ab [Units/volume] in Serum

100

989

1.01

0.02

1.1

8.4

3.4

u/ml

0.78

395

(3023430) Cat dander IgE Ab [Units/volume] in Serum

921

1.01

0.01

1.1

2.0

4.0

u/ml

1.62

377

(3022689) Creatine [Moles/volume] in Urine

233

1.03

0.01

1.7

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

130

1308

0.99

0.01

1.1

2.8

4.7

u/ml

1.60

677

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

394

1.02

0.00

1.4

1.5

8.0

mmol/l

0.00

246

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

106

1.04

0.00

1.1

1.7

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

117

1.03

0.00

1.2

1.1

—

(44806420)

215

0.98

0.00

2.2

2.4

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

16.1

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.1

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

9.9

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

1.00

0.00

1.0

0.0

1.0

u/ml

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.1

—

66.6

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

1.00

0.00

1.0

1.2

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

8.2

—

15.0

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.1

—

42.2

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.98

0.00

1.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint D3_BLOODOTHER and mortality.

Females

Parameter	HR [95% CI]	p-value
D3_BLOODOTHER	3.195 [2.89, 3.53]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.029

During the follow-up period (1.1.1998 — 31.12.2019), 7704 out of 25972 females with D3_BLOODOTHER died.

Males

Parameter	HR [95% CI]	p-value
D3_BLOODOTHER	3.295 [2.94, 3.69]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 7471 out of 21167 males with D3_BLOODOTHER died.

Mortality risk

Mortality risk for people of age

years, who have D3_BLOODOTHER.

N-year risk	Females	Males
1	0.244%	0.68%
5	1.523%	3.577%
10	3.825%	8.513%
15	7.013%	16.125%
20	12.503%	26.374%

Relationships between endpoints

↥

Index endpoint: D3_BLOODOTHER – Other diseases of blood and blood-forming organs, wide

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other diseases of blood and blood-forming organs, wide

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints